JP6715592B2 - Cosmetics containing low molecular weight cationized hyaluronic acid - Google Patents
Cosmetics containing low molecular weight cationized hyaluronic acid Download PDFInfo
- Publication number
- JP6715592B2 JP6715592B2 JP2015239629A JP2015239629A JP6715592B2 JP 6715592 B2 JP6715592 B2 JP 6715592B2 JP 2015239629 A JP2015239629 A JP 2015239629A JP 2015239629 A JP2015239629 A JP 2015239629A JP 6715592 B2 JP6715592 B2 JP 6715592B2
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- molecular weight
- hair
- low molecular
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002674 hyaluronan Polymers 0.000 title claims description 197
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims description 190
- 229960003160 hyaluronic acid Drugs 0.000 title claims description 182
- 239000002537 cosmetic Substances 0.000 title claims description 67
- 210000004209 hair Anatomy 0.000 claims description 73
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 22
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 6
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 6
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 6
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 6
- 238000007696 Kjeldahl method Methods 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 description 66
- 210000003491 skin Anatomy 0.000 description 54
- -1 m/z=134) Substances 0.000 description 40
- 239000000203 mixture Substances 0.000 description 34
- 230000003020 moisturizing effect Effects 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000006210 lotion Substances 0.000 description 22
- 235000014113 dietary fatty acids Nutrition 0.000 description 21
- 239000000194 fatty acid Substances 0.000 description 21
- 229930195729 fatty acid Natural products 0.000 description 21
- 239000008213 purified water Substances 0.000 description 21
- 238000007796 conventional method Methods 0.000 description 16
- 210000002950 fibroblast Anatomy 0.000 description 16
- 238000001179 sorption measurement Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 239000002453 shampoo Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000002500 effect on skin Effects 0.000 description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 11
- 229940010747 sodium hyaluronate Drugs 0.000 description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 11
- 210000003855 cell nucleus Anatomy 0.000 description 10
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000003796 beauty Effects 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000010191 image analysis Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 229920003169 water-soluble polymer Polymers 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 238000002073 fluorescence micrograph Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 229960003237 betaine Drugs 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 102000018866 Hyaluronan Receptors Human genes 0.000 description 5
- 108010013214 Hyaluronan Receptors Proteins 0.000 description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000003696 hair cross section Effects 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 239000013065 commercial product Substances 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 229940097043 glucuronic acid Drugs 0.000 description 4
- 239000003676 hair preparation Substances 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 4
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical class [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- AMFZXVSYJYDGJD-UHFFFAOYSA-M ethyl-dimethyl-(3-methyl-2-oxobut-3-enyl)azanium;chloride Chemical compound [Cl-].CC[N+](C)(C)CC(=O)C(C)=C AMFZXVSYJYDGJD-UHFFFAOYSA-M 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000000282 nail Anatomy 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000002042 time-of-flight secondary ion mass spectrometry Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- LTVDFSLWFKLJDQ-UHFFFAOYSA-N α-tocopherolquinone Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- UVNFMNQJFRLKST-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-decyl-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CC(O)CCl UVNFMNQJFRLKST-UHFFFAOYSA-M 0.000 description 1
- QIKIJFUVHGOQOK-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-dimethyl-octadecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC(O)CCl QIKIJFUVHGOQOK-UHFFFAOYSA-M 0.000 description 1
- AVBRMKWCAQKSHV-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CC(O)CCl AVBRMKWCAQKSHV-UHFFFAOYSA-M 0.000 description 1
- HPLFXTUAVXJDPJ-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-triethylazanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC(O)CCl HPLFXTUAVXJDPJ-UHFFFAOYSA-M 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 1
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical class COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- NPDHNQFIAGGKQV-AAHCGPSESA-L C(CCCCCCCCCCC)(=O)N([C@@H](CCC(=O)[O-])C(=O)[O-])C(CCCCCCCCCCC)=O.N[C@@H](CCCCN)C(=O)O.[Na+].[Na+] Chemical compound C(CCCCCCCCCCC)(=O)N([C@@H](CCC(=O)[O-])C(=O)[O-])C(CCCCCCCCCCC)=O.N[C@@H](CCCCN)C(=O)O.[Na+].[Na+] NPDHNQFIAGGKQV-AAHCGPSESA-L 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical class OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920002387 Phytoglycogen Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 244000171263 Ribes grossularia Species 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- DJIJONCNWZDGHR-UHFFFAOYSA-N butyl acetate;pentyl acetate Chemical compound CCCCOC(C)=O.CCCCCOC(C)=O DJIJONCNWZDGHR-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical class C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- QZEXLLLSWSETON-UHFFFAOYSA-M decyl-dimethyl-(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CC1CO1 QZEXLLLSWSETON-UHFFFAOYSA-M 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- JQHHCVUYAWPCLA-UHFFFAOYSA-M dimethyl-octadecyl-(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1CO1 JQHHCVUYAWPCLA-UHFFFAOYSA-M 0.000 description 1
- ZOYSEKPLCJRBSO-UHFFFAOYSA-M dimethyl-octyl-(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CC1CO1 ZOYSEKPLCJRBSO-UHFFFAOYSA-M 0.000 description 1
- 229940062933 dimethylsilanol hyaluronate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ALNUPAIRBMNLLB-UHFFFAOYSA-M dodecyl-dimethyl-(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1CO1 ALNUPAIRBMNLLB-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 230000003699 hair surface Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- YQFOHQBSENCNTR-UHFFFAOYSA-M oxiran-2-ylmethyl(tripropyl)azanium;chloride Chemical compound [Cl-].CCC[N+](CCC)(CCC)CC1CO1 YQFOHQBSENCNTR-UHFFFAOYSA-M 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- RLQWHDODQVOVKU-UHFFFAOYSA-N tetrapotassium;silicate Chemical compound [K+].[K+].[K+].[K+].[O-][Si]([O-])([O-])[O-] RLQWHDODQVOVKU-UHFFFAOYSA-N 0.000 description 1
- FBEVECUEMUUFKM-UHFFFAOYSA-M tetrapropylazanium;chloride Chemical compound [Cl-].CCC[N+](CCC)(CCC)CCC FBEVECUEMUUFKM-UHFFFAOYSA-M 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- QVOJVKONBAJKMA-UHFFFAOYSA-M triethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1CO1 QVOJVKONBAJKMA-UHFFFAOYSA-M 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は低分子量のカチオン化ヒアルロン酸および/またはその塩を含む化粧料に関する。 The present invention relates to cosmetics containing low molecular weight cationized hyaluronic acid and/or salts thereof.
従来から、ヒトをはじめとする生体内の種々の組織に広く分布して存在し、安全性に優れ、高い保湿効果を有するヒアルロン酸が、様々な皮膚化粧料や毛髪化粧料の一成分として配合されている(例えば特許文献1〜3)。
ヒアルロン酸はグルクロン酸とN−アセチルグルコサミンとの二糖からなる繰り返し構成単位を1以上有する多糖類であり、その構造中にアニオン性のカルボキシル基が存在している。このため、通常マイナスに帯電している皮膚や毛髪の表面に対してヒアルロン酸を適用した場合、電荷の反発によりヒアルロン酸が皮膚等へ吸着しにくいという問題がある。
こうした問題に対して、皮膚等の生体組織への吸着性を高めるべく、第四級アンモニウム基含有基を導入したカチオン化ヒアルロン酸が提案されている(特許文献4)。
Conventionally, hyaluronic acid, which is widely distributed in various tissues in the living body including humans, has excellent safety and has a high moisturizing effect, has been blended as a component of various skin cosmetics and hair cosmetics. (For example, Patent Documents 1 to 3).
Hyaluronic acid is a polysaccharide having at least one repeating constitutional unit composed of a disaccharide of glucuronic acid and N-acetylglucosamine, and has an anionic carboxyl group in its structure. Therefore, when hyaluronic acid is applied to the surface of skin or hair which is normally negatively charged, there is a problem that hyaluronic acid is difficult to be adsorbed to the skin due to repulsion of electric charge.
In order to solve such problems, cationized hyaluronic acid having a quaternary ammonium group-containing group introduced therein has been proposed in order to enhance the adsorptivity to living tissues such as skin (Patent Document 4).
先に提案された特許文献4のカチオン化ヒアルロン酸は、毛髪吸着量や皮膚吸着量が高められたとする結果が示されているものの、毛髪や皮膚の内部への浸透性が悪く、また洗浄によってヒアルロン酸の脱離が起こりやすいという問題がある。
加えて、化粧料に使用する溶媒を始めとする種々の成分との相溶性が低く、配合が限定されるという問題がある。
The cationized hyaluronic acid of the previously proposed Patent Document 4 has been shown to have an increased amount of adsorbed hair and adsorbed on the skin, but has poor permeability to the inside of hair and skin, and is also washed. There is a problem that desorption of hyaluronic acid is likely to occur.
In addition, there is a problem that the compatibility with various components such as a solvent used in cosmetics is low and the formulation is limited.
本発明者らは、上記目的を達成するため鋭意検討を重ねた結果、低分子量のカチオン化ヒアルロン酸および/またはその塩が、生体組織への高い吸着性のみならず組織内部への高い浸透性を有するとともに、溶剤を始めとする種々の化粧料配合成分との高い相溶性を示し、化粧料配合成分として有用であることを見出し、本発明を完成させた。 The inventors of the present invention have conducted extensive studies in order to achieve the above object, and as a result, low molecular weight cationized hyaluronic acid and/or a salt thereof has a high adsorptivity to living tissues as well as a high permeability to the inside of tissues. In addition to having the above-mentioned properties, the compound has high compatibility with various cosmetic ingredients such as solvents, and has been found to be useful as a cosmetic ingredient, and has completed the present invention.
すなわち本発明は、ヒドロキシ基の一部が下記一般式<1>で表される第4級窒素含有基で置換された、分子量が2000〜15,000である低分子量カチオン化ヒアルロン酸および/またはその塩を含む化粧料に関する。
素原子数1〜24のアルキル基またはアルケニル基を表し、X−は1価のアニオンを表す。)
That is, the present invention provides a low molecular weight cationized hyaluronic acid having a molecular weight of 2000 to 15,000 in which a part of hydroxy groups is substituted with a quaternary nitrogen-containing group represented by the following general formula <1> and/or The present invention relates to cosmetics containing the salt.
前記低分子量カチオン化ヒアルロン酸および/またはその塩は、そのカチオン化度が0.30乃至1.00であることが好ましい。
また該低分子量カチオン化ヒアルロン酸および/またはその塩は、化粧料の総質量に対して0.001〜10質量%にて含まれることが好ましい。
The low molecular weight cationized hyaluronic acid and/or its salt preferably has a cationization degree of 0.30 to 1.00.
The low molecular weight cationized hyaluronic acid and/or its salt is preferably contained in 0.001 to 10% by mass based on the total mass of the cosmetic.
また本発明の化粧料は、皮膚用、毛髪用、そして爪用化粧料を好適な対象とするものである。 The cosmetics of the present invention are suitable for cosmetics for skin, hair, and nails.
本発明の化粧料に使用する低分子量のカチオン化ヒアルロン酸は、皮膚や毛髪等の生体組織に対して適用した後、洗浄した後においてもこれら生体組織への高い吸着性を示す。さらに該低分子量のカチオン化ヒアルロン酸は毛髪内部や皮膚内部への浸透性に優れたものとなる。このため、該低分子量カチオン化ヒアルロン酸を配合することにより、本発明の化粧料は、ヒアルロン酸由来の高い保湿効果が持続し、また生体組織内部での保湿効果も実現することができる。
また上記低分子量カチオン化ヒアルロン酸は、溶剤をはじめとする種々の化粧料配合成分と優れた相溶性を示すことから、種々の配合処方に対して適用可能であり、そしてそのため様々な剤形に適用し得るため、様々な毛髪用、肌用そして爪用の化粧料の形態とし、その高い保湿効果を発揮することができる。
The low molecular weight cationized hyaluronic acid used in the cosmetic of the present invention shows high adsorbability to these living tissues even after being applied to the living tissues such as skin and hair and after being washed. Further, the low molecular weight cationized hyaluronic acid has excellent permeability into the hair and the skin. Therefore, by blending the low-molecular-weight cationized hyaluronic acid, the cosmetic of the present invention can maintain a high moisturizing effect derived from hyaluronic acid and also realize a moisturizing effect inside the living tissue.
Further, the low molecular weight cationized hyaluronic acid shows excellent compatibility with various cosmetic ingredients such as solvents, and therefore, it can be applied to various formulation, and therefore can be applied to various dosage forms. Since it can be applied, it can be made into various cosmetic forms for hair, skin and nails and can exhibit its high moisturizing effect.
本発明の化粧料は、低分子量のヒアルロン酸をカチオン化した低分子量カチオン化ヒアルロン酸を含有する。
以下、まず低分子量カチオン化ヒアルロン酸について述べる。
The cosmetic of the present invention contains a low molecular weight cationized hyaluronic acid obtained by cationizing a low molecular weight hyaluronic acid.
Hereinafter, the low molecular weight cationized hyaluronic acid will be described first.
[低分子量カチオン化ヒアルロン酸]
本発明の化粧料に用いるカチオン化ヒアルロン酸および/またはその塩(以下、単にヒアルロン酸とも称する)は、分子量が2,000〜15,000程度の低分子量ヒアルロン酸にカチオン化剤を反応させることにより調製することができる。
[Low molecular weight cationized hyaluronic acid]
The cationized hyaluronic acid and/or its salt (hereinafter also simply referred to as hyaluronic acid) used in the cosmetic of the present invention comprises reacting a low molecular weight hyaluronic acid having a molecular weight of about 2,000 to 15,000 with a cationizing agent. Can be prepared by
ヒアルロン酸は、グルクロン酸とN−アセチルグルコサミンとの二糖からなる繰り返し構成単位を1以上有するムコ多糖類であり、例えば、鶏冠のトサカなどの生体組織からの抽出、あるいは微生物を用いた培養などにより工業的に生産されており、その塩(ナトリウム塩など)を含め市販として入手できる。 Hyaluronic acid is a mucopolysaccharide having at least one repeating constitutional unit composed of a disaccharide of glucuronic acid and N-acetylglucosamine, and is extracted from living tissues such as gooseberry of a chicken cob or cultivated by using a microorganism. Are produced industrially by and are commercially available, including their salts (such as sodium salts).
天然由来のヒアルロン酸の分子量は通常50万以上であることから、本発明では、酸や
アルカリの存在下で加水分解したり、ヒアルロニダーゼなどの酵素を用いて処理したり、または超音波や剪断によって物理的に切断することにより、低分子量化したヒアルロン酸を原料として採用することが好ましい。
また、ヒアルロン酸の塩としては特に限定されず、上記ナトリウム塩のほか、カリウム塩、カルシウム塩、亜鉛塩、マグネシウム塩、アンモニウム塩等が挙げられ、薬学上許容し得る塩であれば好ましく用いることができる。
Since the molecular weight of naturally-occurring hyaluronic acid is usually 500,000 or more, in the present invention, it is hydrolyzed in the presence of acid or alkali, treated with an enzyme such as hyaluronidase, or ultrasonically or sheared. It is preferable to employ, as a raw material, hyaluronic acid whose molecular weight has been reduced by physically cutting it.
Further, the salt of hyaluronic acid is not particularly limited, and in addition to the above-mentioned sodium salt, potassium salt, calcium salt, zinc salt, magnesium salt, ammonium salt and the like can be mentioned, and it is preferably used if it is a pharmaceutically acceptable salt. You can
なおヒアルロン酸は、一般に800〜250万程度の分子量を有するものが知られており、本発明において、おおよそ平均分子量が15,000以下のものを低分子量ヒアルロン酸、100万以上のものを高分子量ヒアルロン酸、10,000〜100万程度のものを中分子量ヒアルロン酸と称する。
本発明において、ヒアルロン酸の分子量は、ゲル浸透クロマトグラフィー(GPC)により測定される値である。なお一般に、特に高分子量のヒアルロン酸の分子量についてはその動粘度から極限粘度を求め、この極限粘度から分子量に換算する方法によって得ることができる。
Hyaluronic acid is generally known to have a molecular weight of about 8 to 2.5 million. In the present invention, those having an average molecular weight of about 15,000 or less are low molecular weight hyaluronic acid, and those having a molecular weight of 1 million or more are high molecular weight. Hyaluronic acid, about 10,000 to 1,000,000 is called medium molecular weight hyaluronic acid.
In the present invention, the molecular weight of hyaluronic acid is a value measured by gel permeation chromatography (GPC). In general, the molecular weight of hyaluronic acid having a high molecular weight can be obtained by a method of determining the intrinsic viscosity from the kinematic viscosity and converting the intrinsic viscosity into the molecular weight.
本発明の化粧料に用いる低分子量のカチオン化ヒアルロン酸は、ヒアルロン酸のヒドロキシ基の一部が下記一般式<1>で表される第4級窒素含有基で置換されてなるものである。
前記化学式<1>で表される第4級窒素含有基において、R1およびR2における炭素原子数1乃至3のアルキル基の具体例としては、メチル基、エチル基およびプロピル基が挙げられる。
またR3における炭素原子数1乃至24のアルキル基の具体例としては、メチル基、エチル基、プロピル基、ブチル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシル基、ドデシル基、テトラデシル基、ヘキサデシル基、オクタデシル基、イコシル基、ドコシル基、テトラコシル基等が挙げられ、これらは直鎖状、分岐鎖状、環状のいずれであってもよい。また炭素原子数1乃至24のアルケニル基としては、上記アルキル基において任意の一つの炭素−炭素単結合が炭素―炭素二重結合に置換された基を表し、例えばオレイル基等が挙げられる。
また、アニオンX−の具体例としては、塩素イオン、臭素イオンおよびヨウ素イオンなどのハロゲンイオンの他、メチル硫酸イオン、エチル硫酸イオン、酢酸イオン等を挙げることができる。
In the quaternary nitrogen-containing group represented by the chemical formula <1>, specific examples of the alkyl group having 1 to 3 carbon atoms in R 1 and R 2 include a methyl group, an ethyl group and a propyl group.
Specific examples of the alkyl group having 1 to 24 carbon atoms in R 3 include methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, heptyl group, octyl group, nonyl group, decyl group and dodecyl group. Examples thereof include a group, a tetradecyl group, a hexadecyl group, an octadecyl group, an icosyl group, a docosyl group and a tetracosyl group, which may be linear, branched or cyclic. Further, the alkenyl group having 1 to 24 carbon atoms represents a group in which any one carbon-carbon single bond in the above alkyl group is substituted with a carbon-carbon double bond, and examples thereof include an oleyl group.
Specific examples of the anion X − include halogen ions such as chlorine ion, bromine ion and iodine ion, as well as methylsulfate ion, ethylsulfate ion and acetate ion.
上記低分子量ヒアルロン酸のカチオン化は、原料であるヒアルロン酸に、第4級窒素含有基を有するカチオン化剤と反応させることにより行うことができる。より詳細には、ヒアルロン酸の構造中、グルクロン酸由来のカルボキシル基におけるOH部分(ヒドロキシ基)、および/またはヒアルロン酸の構造中に存在する上記以外のヒドロキシ基に対して、第4級窒素含有基を有するカチオン化剤を反応させることにより、カチオン化ヒアルロン酸を得ることができる。
この反応は、適当な溶媒、好適には含水アルコール中において、アルカリの存在下で実
施される。このような第4級窒素含有基の導入は、従来公知の方法に従って行うことができ、必ずしもこれらに限定されるものではない。また、反応時に溶媒中での低分子量ヒアルロン酸の凝集を防ぐため、無機塩、好適には塩化ナトリウムを添加してもよい。
The cationization of the low molecular weight hyaluronic acid can be carried out by reacting hyaluronic acid as a raw material with a cationizing agent having a quaternary nitrogen-containing group. More specifically, in the structure of hyaluronic acid, the OH moiety (hydroxy group) in the carboxyl group derived from glucuronic acid, and/or the hydroxy group other than the above present in the structure of hyaluronic acid, a quaternary nitrogen-containing group is included. Cationized hyaluronic acid can be obtained by reacting a cationizing agent having a group.
This reaction is carried out in the presence of alkali in a suitable solvent, preferably hydroalcoholic. The introduction of such a quaternary nitrogen-containing group can be carried out according to a conventionally known method, and is not necessarily limited thereto. Further, an inorganic salt, preferably sodium chloride, may be added to prevent aggregation of low molecular weight hyaluronic acid in the solvent during the reaction.
上記カチオン化剤としては、2,3−エポキシプロピルトリアルキルアンモニウムハライド(グリシジルトリアルキルアンモニウム塩)または3−ハロゲノ−2−ヒドロキシプロピルトリアルキルアンモニウムハライド等の第四級アンモニウム基を含有するカチオン化剤を好適に用いることができ、これらは単独で使用してもよいし、あるいは二種以上を組み合わせて使用してもよい。
上記2,3−エポキシプロピルトリアルキルアンモニウムハライド(グリシジルトリアルキルアンモニウム塩)としては、例えば、グリシジルトリメチルアンモニウムクロリド、グリシジルトリエチルアンモニウムクロリド、グリシジルトリプロピルアンモニウムクロリド、グリシジルジメチルオクチルアンモニウムクロリド、グリシジルジメチルデシルアンモニウムクロリド、グリシジルジメチルラウリルアンモニウムクロリド、グリシジルジメチルステアリルアンモニウムクロリド等が挙げられる。
また、3−ハロゲノ−2−ヒドロキシプロピルトリアルキルアンモニウムハライドとしては、例えば、3−クロロ−2−ヒドロキシプロピルトリメチルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルトリエチルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルトリプロピルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルジメチルオクチルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルジメチルデシルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルジメチルラウリルアンモニウムクロリド、3−クロロ−2−ヒドロキシプロピルジメチルステアリルアンモニウムクロリド等が挙げられる。
これらのなかでも、カチオン化剤として、3−クロロ−2−ヒドロキシプロピルトリメチルアンモニウムクロリドおよびグリシジルトリメチルアンモニウムクロリドもしくはいずれか一方を用いることが好ましい。
As the cationizing agent, a cationizing agent containing a quaternary ammonium group such as 2,3-epoxypropyltrialkylammonium halide (glycidyltrialkylammonium salt) or 3-halogeno-2-hydroxypropyltrialkylammonium halide Can be preferably used, and these may be used alone or in combination of two or more kinds.
Examples of the 2,3-epoxypropyltrialkylammonium halide (glycidyltrialkylammonium salt) include glycidyltrimethylammonium chloride, glycidyltriethylammonium chloride, glycidyltripropylammonium chloride, glycidyldimethyloctylammonium chloride, glycidyldimethyldecylammonium chloride. , Glycidyl dimethyl lauryl ammonium chloride, glycidyl dimethyl stearyl ammonium chloride and the like.
Examples of 3-halogeno-2-hydroxypropyltrialkylammonium halides include 3-chloro-2-hydroxypropyltrimethylammonium chloride, 3-chloro-2-hydroxypropyltriethylammonium chloride, 3-chloro-2-hydroxy. Propyltripropylammonium chloride, 3-chloro-2-hydroxypropyldimethyloctylammonium chloride, 3-chloro-2-hydroxypropyldimethyldecylammonium chloride, 3-chloro-2-hydroxypropyldimethyllaurylammonium chloride, 3-chloro-2 -Hydroxypropyl dimethyl stearyl ammonium chloride and the like can be mentioned.
Among these, it is preferable to use 3-chloro-2-hydroxypropyltrimethylammonium chloride and/or glycidyltrimethylammonium chloride as the cationizing agent.
本発明の化粧料は、毛髪や皮膚等の改質効果(保湿効果など)並びに化粧料への配合のしやすさの観点から、前述の通り分子量2,000〜15,000のカチオン化ヒアルロン酸を使用するものであり、好ましくは分子量が3,000〜12,000、より好ましくは分子量が5,000〜10,000であることが好ましい。
カチオン化ヒアルロン酸の分子量が15,000を超えると、配合した化粧料を適用した後、洗浄によって容易にカチオン化ヒアルロン酸が毛髪や皮膚表面から脱離しやすくなり、毛髪内部や皮膚内部への浸透性が低くなるだけでなく、他の化粧料配合成分との相溶性が悪くなる虞がある。また分子量が2,000を下回ると、ヒアルロン酸が保有する保湿効果が発揮しにくくなる。
The cosmetic of the present invention is a cationized hyaluronic acid having a molecular weight of 2,000 to 15,000 as described above, from the viewpoints of the effect of modifying hair and skin (moisture retaining effect, etc.) and the ease of incorporation into cosmetics. It is preferable that the molecular weight is 3,000 to 12,000, and more preferably the molecular weight is 5,000 to 10,000.
If the molecular weight of the cationized hyaluronic acid exceeds 15,000, the cationized hyaluronic acid can easily be detached from the hair or the skin surface by washing after applying the blended cosmetics, and penetrates into the hair or the skin. In addition to lowering the compatibility, the compatibility with other cosmetic ingredients may deteriorate. When the molecular weight is less than 2,000, the moisturizing effect possessed by hyaluronic acid becomes difficult to be exhibited.
本発明の化粧料において、カチオン化ヒアルロン酸のカチオン化度は0.30〜1.00であり、好ましくは0.55〜0.90であり、さらに好ましくは0.65〜0.80である。
上記カチオン化度が0.30未満では毛髪や皮膚に対する吸着量が不十分となり、実際、シャンプー、リンス、ボディ用洗浄剤等の毛髪処理組成物や、化粧水、美容液等の皮膚化粧料組成物に配合しても、保湿効果などの十分な効果を得ることができない。また、カチオン化度が1.0を超えると、そのようなカチオン化ヒアルロン酸を配合した毛髪処理用組成物および皮膚化粧料組成物を使用しても、使用時に泡立ちの悪化および、べたつき感、ぬるつき感が生じてしまい、使用感を悪化させ、使用後の仕上がり感も、ごわつき感、べたつき感を生じるなど好ましくない。
In the cosmetic of the present invention, the degree of cationization of cationized hyaluronic acid is 0.30 to 1.00, preferably 0.55 to 0.90, and more preferably 0.65 to 0.80. ..
If the degree of cationization is less than 0.30, the amount adsorbed to hair and skin becomes insufficient, and in fact, a hair treatment composition such as shampoo, conditioner and body cleaner, and a skin cosmetic composition such as lotion and beauty essence. Even if it is blended with a product, a sufficient effect such as a moisturizing effect cannot be obtained. Further, when the degree of cationization exceeds 1.0, even when a hair treatment composition and a skin cosmetic composition containing such a cationized hyaluronic acid are used, foaming is deteriorated and stickiness is felt during use. A slimy feeling is caused, which deteriorates the feeling of use, and the finished feeling after use is not preferable, such as a feeling of stiffness and a feeling of stickiness.
なお本発明において、カチオン化ヒアルロン酸のカチオン化度とは、式<1>で表される第4級窒素含有基に由来する値を意味し、すなわち、カチオン化ヒアルロン酸を構成す
る繰り返し構成単位(グルクロン酸とN−アセチルグルコサミンからなる二糖)当たりに結合する上記化学式<1>で表される第4級窒素含有基の数(置換度)を表す。
In the present invention, the cationization degree of the cationized hyaluronic acid means a value derived from the quaternary nitrogen-containing group represented by the formula <1>, that is, the repeating constitutional unit constituting the cationized hyaluronic acid. The number (degree of substitution) of the quaternary nitrogen-containing group represented by the above chemical formula <1> bound per (disaccharide consisting of glucuronic acid and N-acetylglucosamine).
一般にカチオン化化合物のカチオン化度は、第4級窒素含有基由来の窒素分をケルダール法[医薬部外品原料規格2006、一般試験方法、窒素定量法、第2法(ケルダール法)(第37頁右欄〜第19頁右欄参照)]により定量し、得られた測定値から算出される値である。ただし本発明で用いるヒアルロン酸の構造中には、N−アセチルグルコサミン由来の窒素原子が存在するため、上記ケルダール法により求めたカチオン化ヒアルロン酸中の窒素分(測定値)から、原料となるヒアルロン酸(N−アセチルグルコサミン)由来の窒素分を引いた値が、本発明で用いるカチオン化ヒアルロン酸のカチオン化度(第4級窒素含有基由来の窒素分)となる。
例えば、前記化学式<1>においてR1、R2およびR3がいずれもメチル基を表し、X−は塩素イオンを表すところの第4級窒素含有基でヒアルロン酸をカチオン変性し、得られたカチオン変性ヒアルロン酸の窒素分をケルダール法により測定した結果、5.6%であった場合、カチオン化度は以下の式にて算出される。なお本発明で用いられるヒアルロン酸中には、通常窒素分を3.5%前後含有している。また式中の「カチオン化置換部分の分子量」とは、ヒドロキシ基と置換する化学式<1>の第4級窒素含有基において、置換により改変された部分(すなわち、式<1>中における結合端である酸素原子以外の部分)の分子量を指す。
For example, in the above chemical formula <1>, R 1 , R 2 and R 3 each represent a methyl group, and X − is a quaternary nitrogen-containing group in which a hyaluronic acid is cation-modified and is obtained. When the nitrogen content of the cation-modified hyaluronic acid was measured by the Kjeldahl method to be 5.6%, the degree of cationization is calculated by the following formula. The hyaluronic acid used in the present invention usually contains about 3.5% nitrogen. Further, the "molecular weight of the cationized substitution portion" in the formula means a portion of the quaternary nitrogen-containing group of the chemical formula <1> that substitutes with a hydroxy group, which is modified by the substitution (ie, the bonding end in the formula <1>). The part other than the oxygen atom) is a molecular weight.
なお上記カチオン化度は、上記の方法以外に、トルイジンブルー水溶液を指示薬とし、ポリビニル硫酸カリウム水溶液で滴定するコロイド滴定法(化粧品種別配合成分規格、塩化O−〔2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル〕ヒドロキシエチルセルロース、定量法)によっても求めることができる。 In addition to the above methods, the degree of cationization is a colloid titration method in which an aqueous solution of toluidine blue is used as an indicator and titration is performed with an aqueous solution of potassium polyvinyl sulfate (compounding component standards according to makeup product type, chloride O-[2-hydroxy-3-(trimethylammonium chloride)). E) Propyl] hydroxyethyl cellulose, quantitative method).
[化粧料]
本発明の化粧料において、上記低分子量カチオン化ヒアルロン酸(固形分換算)の配合量は、化粧料全体を100質量%として、0.001〜10質量%、好ましくは0.01〜1質量%とすることが好ましい。配合量が0.001質量%未満ではコンディショニング効果、セット性が十分に発揮されない傾向にあり、10質量%を越えると使用時にぬるつき感、べたつき感が生じると共に、柔軟性が悪化し、ごわつき感を生じ使用感が悪くなる傾向があり、また経済性の観点からも好適でない。上記配合量は、より好ましくは0.1〜0.5質量%である。
[Cosmetic]
In the cosmetic of the present invention, the compounding amount of the low molecular weight cationized hyaluronic acid (solid content conversion) is 0.001 to 10% by mass, preferably 0.01 to 1% by mass, based on 100% by mass of the entire cosmetic. It is preferable that If the blending amount is less than 0.001% by mass, the conditioning effect and the setting property tend not to be sufficiently exhibited, and if the blending amount exceeds 10% by mass, a slimy feeling and a sticky feeling are generated at the time of use and the flexibility is deteriorated, and a stiff feeling is generated. Tend to occur and the usability tends to deteriorate, and it is not preferable from the viewpoint of economy. The blending amount is more preferably 0.1 to 0.5% by mass.
本発明の化粧料は、皮膚用(肌用)化粧料、毛髪用化粧料、さらには爪用化粧料等のいずれの種類の化粧料とすることができる。
上述の本発明にかかる化粧料の剤型は限定されず任意の剤型を取ることができ、さらに上記(必須)成分の他に本発明の効果を損なわない範囲で、その剤型によって通常当該化粧料に配合される各種成分を加え常法により製造することができる。
The cosmetic of the present invention can be any kind of cosmetics such as skin (skin) cosmetics, hair cosmetics, and nail cosmetics.
The dosage form of the cosmetic according to the present invention described above is not limited and can be any dosage form. Further, in addition to the above (essential) components, the dosage form is usually selected depending on the dosage form. It can be produced by a conventional method by adding various components to be mixed with the cosmetic.
皮膚用(肌用)化粧料としては、洗顔料、洗浄料、化粧水(例えば、美白化粧水等)、クリーム(例えば、バニシングクリーム、コールドクリーム)、乳液、美容液、パック(例えば、ゼリー状ピールオフタイプ、ペースト状拭き取りタイプ、粉末状洗い流しタイプ
等)、クレンジング、ファンデーション、口紅、リップクリーム、リップグロス、リップライナー、頬紅、マスカラ、アイライナー、アイブロウ、シェービングローション、アフターシェービングローション、日焼け止め(クリーム、ジェル等)、タンニング剤(ローション、クリーム等)、アフターサンケア製品(ローション、ジェル等)、デオドラントローション、ボディローション(ハンドケアローション、フットケアローション等を含む)、ボディクリーム(ハンドクリーム等を含む)、ボディオイル、石鹸、ボディソープ(ボディシャンプー)および入浴剤等の、基礎化粧料、メイクアップ用化粧料、ボディ用化粧料など種々の化粧料が挙げられる。
また毛髪用化粧料としては、例えば、シャンプー、リンス、リンス一体型シャンプー、ヘアコンディショナー、ヘアトリートメント、ヘアパック、ヘアクリーム、ヘアスタイリング、ヘアワックス、ヘアジェル、ヘアフォーム(ヘアムース)、ヘアローション、ヘアスプレー、ヘアオイル、ヘアトニック、養毛剤、パーマネント液、ヘアカラー、ヘアカラー前処理液、ヘアマスカラ、ヘアマスカラクレンジング剤等が挙げられる。これら毛髪化粧料は、毛髪に適用後に短時間で洗い流すタイプの化粧料(例えばシャンプー等)、或いは、適用後に洗い流さないタイプの化粧料(例えばヘアクリーム等)のいずれであってもよい。
さらに、爪用化粧料としては、ネイルクリーム、ネイルトリートメント、ネイルオイル、ネイルリムーバー等が挙げられる。
Examples of skin (skin) cosmetics include facial cleanser, detergent, lotion (for example, whitening lotion), cream (for example, vanishing cream, cold cream), milky lotion, beauty essence, pack (for example, jelly form). Peel off type, paste wipe type, powder wash type, etc.), cleansing, foundation, lipstick, lip balm, lip gloss, lip liner, blusher, mascara, eyeliner, eyebrow, shaving lotion, after shaving lotion, sunscreen (cream) , Gel etc.), tanning agent (lotion, cream etc.), after-sun care product (lotion, gel etc.), deodorant lotion, body lotion (including hand care lotion, foot care lotion etc.), body cream (including hand cream etc.) Various cosmetics such as basic cosmetics, makeup cosmetics, body cosmetics such as body oil, soap, body soap (body shampoo) and bath salts.
Examples of hair cosmetics include shampoo, conditioner, conditioner-inclusive shampoo, hair conditioner, hair treatment, hair pack, hair cream, hair styling, hair wax, hair gel, hair foam (hair mousse), hair lotion, hair spray. , Hair oil, hair tonic, hair nourishing agent, permanent liquid, hair color, hair color pretreatment liquid, hair mascara, hair mascara cleansing agent and the like. These hair cosmetics may be either a type of cosmetic that is washed off in a short time after being applied to hair (such as shampoo) or a type of cosmetic that is not rinsed after application (such as hair cream).
Further, examples of the nail cosmetics include nail cream, nail treatment, nail oil, nail remover and the like.
本発明の化粧料にはコンディショニング効果、肌保護効果の向上の為、本発明の低分子量カチオン化ヒアルロン酸の他に、さらに種々のカチオン性水溶性高分子、両性水溶性高分子を併用することができるが、その配合量は、本発明の低分子量カチオン化ヒアルロン酸を含む化粧料の繰り返し使用時の感触、安定性などを損なわない範囲であり、化粧料全体を100質量%として、5質量%以下が好ましく、これを超えると使用時にごわつき感が生じ使用感が悪くなる。さらに、皮膚化粧料に於いては、剤型の安定性の悪化、および感触面ではぬるつき感が生じ、使用感が悪くなる。 In order to improve the conditioning effect and the skin protection effect, the cosmetic of the present invention may further contain various cationic water-soluble polymers and amphoteric water-soluble polymers in addition to the low molecular weight cationized hyaluronic acid of the present invention. However, the blending amount thereof is within a range that does not impair the feel, stability, etc. during repeated use of the cosmetic composition containing the low molecular weight cationized hyaluronic acid of the present invention, and the total amount of the cosmetic composition is 5% by mass. % Or less is preferable, and if it exceeds this, a feeling of stiffness is generated at the time of use and the usability is deteriorated. Further, in skin cosmetics, the stability of the dosage form is deteriorated, and the feeling of touch causes a slimy feel, resulting in a poor feeling in use.
配合されるカチオン性水溶性高分子、両性水溶性高分子としては、下記のようなものが挙げられるが、必ずしもこれらに限定されるものではない。 Examples of the cationic water-soluble polymer and amphoteric water-soluble polymer to be blended include the following, but are not necessarily limited thereto.
カチオン性水溶性高分子の例としては、第4級窒素変性ポリサッカライド(カチオン変性フェヌグリークガム、カチオン変性グアーガム、カチオン変性タラガム、カチオン変性ローカストビーンガム、カチオン変性デンプン、カチオン変性タマリンドガム、カチオン変性ヒドロキシエチルセルロース、カチオン変性デキストラン、カチオン変性キトサン、カチオン変性ハチミツ等)、塩化ジメチルジアリルアンモニウム誘導体(塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体、ポリ塩化ジメチルメチレンピペリジニウム、ポリジメチルジアリルアンモニウムハライド型カチオン性ポリマー等)、ビニルピロリドン誘導体(ビニルピロリドン・ジメチルアミノエチルメタクリル酸共重合体塩、ビニルピロリドン・メタクリルアミドプロピルトリメチルアンモニウムクロリド共重合体、ビニルピロリドン・塩化メチルビニルイミダゾリウム共重合体等)、メタクリル酸誘導体(メタクリロイルエチルジメチルベタイン・塩化メタクリロイルエチルトリメチルアンモニウム・メタクリル酸2−ヒドロキシエチル共重合体、メタクリロイルエチルジメチルベタイン・塩化メタクリロイルエチルトリメチルアンモニウム・メタクリル酸メトキシポリエチレングリコール共重合体等)等が挙げられる。 Examples of the cationic water-soluble polymer include quaternary nitrogen-modified polysaccharides (cation-modified fenugreek gum, cation-modified guar gum, cation-modified tara gum, cation-modified locust bean gum, cation-modified starch, cation-modified tamarind gum, cation-modified hydroxy). Ethyl cellulose, cation-modified dextran, cation-modified chitosan, cation-modified honey, etc.), dimethyldiallylammonium chloride derivative (dimethyldiallylammonium chloride/acrylamide copolymer, polydimethylmethylenepiperidinium chloride, polydimethyldiallylammonium halide type cationic polymer, etc.) ), vinylpyrrolidone derivatives (vinylpyrrolidone/dimethylaminoethylmethacrylic acid copolymer salt, vinylpyrrolidone/methacrylamidopropyltrimethylammonium chloride copolymer, vinylpyrrolidone/methylvinylimidazolium chloride copolymer, etc.), methacrylic acid derivatives ( Examples thereof include methacryloylethyl dimethyl betaine/methacryloyl ethyl trimethyl ammonium chloride/2-hydroxyethyl methacrylate copolymer, methacryloyl ethyl dimethyl betaine/methacryloyl ethyl trimethyl ammonium chloride/methacrylic acid methoxy polyethylene glycol copolymer, and the like.
両性水溶性高分子の例としては、両性化デンプン、塩化ジメチルジアリルアンモニウム誘導体(アクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体、アクリル酸・塩化ジメチルジアリルアンモニウム共重合体等)、メタクリル酸誘導体(ポリメタクリロイルエチルジメチルベタイン、N−メタクリロイルオキシエチル−N,N−ジメチルアンモニウム−α−メチルカルボキシベタイン・メタクリル酸アルキル共重合体等
)等が挙げられる。
Examples of the amphoteric water-soluble polymer include amphoteric starch, dimethyldiallylammonium chloride derivative (acrylamide/acrylic acid/dimethyldiallylammonium chloride copolymer, acrylic acid/dimethyldiallylammonium chloride copolymer, etc.), methacrylic acid derivative ( Polymethacryloylethyl dimethyl betaine, N-methacryloyloxyethyl-N,N-dimethylammonium-α-methylcarboxybetaine/alkyl methacrylate copolymer, etc.) and the like.
さらに本発明の化粧料は、上述の低分子量のカチオン化ヒアルロン酸に加えて、化粧料に通常配合される種々の成分を適宜配合し得る。配合可能な他の成分を下記に例示するがこれら成分に限定されるものではない。 Further, in the cosmetic of the present invention, in addition to the above-mentioned cationized hyaluronic acid having a low molecular weight, various components usually mixed in the cosmetic can be appropriately mixed. Other components that can be mixed are illustrated below, but the components are not limited to these components.
例えば界面活性剤として、アニオン界面活性剤としては、アルキル(炭素原子数8〜24)硫酸塩、アルキル(炭素原子数8〜24)エーテル硫酸塩、アルキル(炭素原子数8〜24)ベンゼンスルホン酸塩、アルキル(炭素原子数8〜24)スルホコハク酸塩、ポリオキシアルキレンアルキル(炭素原子数8〜24)エーテルスルホコハク酸塩、アルキル(炭素原子数8〜24)リン酸塩、ポリオキシアルキレンアルキル(炭素原子数8〜24)エーテルリン酸塩、アシル(炭素原子数8〜24)化タウリン塩、アシル(炭素原子数8〜24)化メチルタウリン塩、アシル(炭素原子数8〜24)化アラニン塩、アシル(炭素原子数8〜24)化N−メチル−β−アラニン塩、アシル(炭素原子数8〜24)化グルタミン酸塩、アシル(炭素原子数8〜24)化イセチオン酸塩、アシル(炭素原子数8〜24)化サルコシン酸塩、α−スルホ脂肪酸エステル塩、エーテルカルボン酸塩、長鎖(炭素原子数8〜24)カルボン酸塩、ポリオキシアルキレン脂肪酸モノエタノールアミド硫酸塩等が挙げられる。
ノニオン界面活性剤としては、アルカノールアミド、グリセリン脂肪酸エステル、ポリオキシアルキレンアルキルエーテル、ポリオキシアルキレングリコールエーテル、ポリオキシアルキレンソルビタン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシアルキレンソルビット脂肪酸エステル、ソルビット脂肪酸エステル、ポリオキシアルキレングリセリン脂肪酸エステル、ポリオキシアルキレン脂肪酸エステル、ポリオキシアルキレンアルキルフェニルエーテル、テトラポリオキシアルキレンエチレンジアミン縮合物類、ショ糖脂肪酸エステル、ポリオキシアルキレン脂肪酸アミド、ポリオキシアルキレングリコール脂肪酸エステル、ポリオキシアルキレンヒマシ油誘導体、ポリオキシアルキレン硬化ヒマシ油誘導体、アルキルポリグリコシド、ポリグリセリン脂肪酸エステル等が挙げられる。
両性界面活性剤としては、アルキル(炭素原子数8〜24)ベタイン、アルキル(炭素原子数8〜24)アミドプロピルベタイン、アルキル(炭素原子数8〜24)カルボキシベタイン、アルキル(炭素原子数8〜24)スルホベタイン、アルキル(炭素原子数8〜24)ヒドロキシスルホベタイン、アルキル(炭素原子数8〜24)アミドプロピルヒドロキシスルホベタイン、アルキル(炭素原子数8〜24)ヒドロキシホスホベタイン、アルキル(炭素原子数8〜24)アミノカルボン酸塩、アルキル(炭素原子数8〜24)アンホ酢酸ナトリウム、アルキル(炭素原子数8〜24)アミンオキシド、3級窒素、および4級窒素を含むアルキル(炭素原子数8〜24)リン酸エステル、イミダゾリニウムベタイン、卵黄レシチン、大豆レシチン等が挙げられる。
For example, as the surfactant, as the anionic surfactant, alkyl (8 to 24 carbon atoms) sulfate, alkyl (8 to 24 carbon atoms) ether sulfate, alkyl (8 to 24 carbon atoms) benzenesulfonic acid Salts, alkyl (8 to 24 carbon atoms) sulfosuccinates, polyoxyalkylene alkyl (8 to 24 carbon atoms) ether sulfosuccinates, alkyl (8 to 24 carbon atoms) phosphates, polyoxyalkylene alkyl ( C8-C24 ether phosphates, acyl (C8-24)-modified taurine salts, acyl (C8-24)-methyl taurine salts, acyl (C8-24)-alanine Salts, acyl (8 to 24 carbon atoms)-modified N-methyl-β-alanine salts, acyl (8 to 24 carbon atoms) glutamate, acyl (8 to 24 carbon atoms) isethionates, acyl ( Examples include sarcosinate having 8 to 24 carbon atoms, α-sulfofatty acid ester salt, ether carboxylate, long-chain (8 to 24 carbon atoms) carboxylate, polyoxyalkylene fatty acid monoethanolamide sulfate, and the like. To be
As the nonionic surfactant, alkanolamide, glycerin fatty acid ester, polyoxyalkylene alkyl ether, polyoxyalkylene glycol ether, polyoxyalkylene sorbitan fatty acid ester, sorbitan fatty acid ester, polyoxyalkylene sorbit fatty acid ester, sorbit fatty acid ester, polyoxy Alkylene glycerin fatty acid ester, polyoxyalkylene fatty acid ester, polyoxyalkylene alkyl phenyl ether, tetrapolyoxyalkylene ethylene diamine condensate, sucrose fatty acid ester, polyoxyalkylene fatty acid amide, polyoxyalkylene glycol fatty acid ester, polyoxyalkylene castor oil Examples thereof include derivatives, polyoxyalkylene hydrogenated castor oil derivatives, alkyl polyglycosides, and polyglycerin fatty acid esters.
Examples of the amphoteric surfactant include alkyl (8 to 24 carbon atoms) betaine, alkyl (8 to 24 carbon atoms) amidopropyl betaine, alkyl (8 to 24 carbon atoms) carboxybetaine, alkyl (8 to 24 carbon atoms). 24) Sulfobetaine, alkyl (8 to 24 carbon atoms) hydroxysulfobetaine, alkyl (8 to 24 carbon atoms) amidopropyl hydroxysulfobetaine, alkyl (8 to 24 carbon atoms) hydroxyphosphobetaine, alkyl (carbon atoms Number 8 to 24) Aminocarboxylic acid salt, alkyl (C 8 to C 24) sodium amphoacetate, alkyl (C 8 to C 24) amine oxide, alkyl containing tertiary nitrogen, and quaternary nitrogen (number of carbon atoms) 8-24) Phosphate ester, imidazolinium betaine, egg yolk lecithin, soybean lecithin and the like.
また本発明の化粧料に配合され得る上記カチオン性、両性水溶性高分子以外にも、粘度調整、およびスタイリング時の使用性をある程度改善するなどの目的によりアニオン性、ノニオン性高分子を、本発明の効果を損なわない範囲でさらに配合することができ、例えば下記のようなものが挙げられる。 In addition to the above cationic and amphoteric water-soluble polymers that can be blended in the cosmetics of the present invention, anionic and nonionic polymers are used for the purpose of adjusting viscosity and improving the usability during styling to some extent. It may be further compounded within a range that does not impair the effects of the invention, and examples thereof include the following.
アニオン性高分子の例としては、アクリル酸誘導体(ポリアクリル酸およびその塩、アクリル酸・アクリルアミド・アクリル酸エチル共重合体およびその塩等)、メタクリル酸誘導体(ポリメタクリル酸およびその塩、メタクリル酸・アクリルアミド・ジアセトンアクリルアミド・アクリル酸アルキルエステル・メタクリル酸アルキルエステル共重合体およびその塩等)、クロトン酸誘導体(酢酸ビニル・クロトン酸共重合体等)、マレイン酸誘導体(無水マレイン酸・ジイソブチレン共重合体、イソブチレン・マレイン酸共重合体等)、ポリグルタミン酸およびその塩、ヒアルロン酸およびその塩、カルボキシメチルセ
ルロース、カルボキシビニルポリマー等が挙げられる。
ノニオン性高分子の例としては、アクリル酸誘導体(アクリル酸ヒドロキシエチル・アクリル酸メトキシエチル共重合体、ポリアクリル酸アミド等)、ビニルピロリドン誘導体(ポリビニルピロリドン、ビニルピロリドン・酢酸ビニル共重合体等)、ポリオキシアルキレングリコール誘導体(ポリエチレングリコール、ポリプロピレングリコール等)、セルロース誘導体(メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース等)、ポリサッカライドおよびその誘導体(グアーガム、ローカストビーンガム、デキストラン等)等が挙げられる。
Examples of the anionic polymer include acrylic acid derivatives (polyacrylic acid and salts thereof, acrylic acid/acrylamide/ethyl acrylate copolymers and salts thereof), methacrylic acid derivatives (polymethacrylic acid and salts thereof, methacrylic acid).・Acrylamido/diacetone acrylamide/alkyl acrylate/methacrylic acid alkyl ester copolymers and salts, etc., crotonic acid derivatives (vinyl acetate/crotonic acid copolymers etc.), maleic acid derivatives (maleic anhydride/diisobutylene) Copolymers, isobutylene/maleic acid copolymers, etc.), polyglutamic acid and its salts, hyaluronic acid and its salts, carboxymethylcellulose, carboxyvinyl polymers and the like.
Examples of nonionic polymers include acrylic acid derivatives (hydroxyethyl acrylate/methoxyethyl acrylate copolymer, polyacrylic acid amide, etc.), vinylpyrrolidone derivatives (polyvinylpyrrolidone, vinylpyrrolidone/vinyl acetate copolymer, etc.) , Polyoxyalkylene glycol derivatives (polyethylene glycol, polypropylene glycol, etc.), cellulose derivatives (methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, etc.), polysaccharides and their derivatives (guar gum, locust bean gum, dextran, etc.) and the like.
さらに別の態様において、本発明の化粧料に、アミドアミン化合物を有機酸および/または無機酸等の中和剤で完全中和または部分中和したアミドアミン化合物の有機酸塩および/または無機酸塩とさらに、高級脂肪酸および/または高級アルコールを添加することで、コンディショニング効果を向上することができる。その配合量はアミドアミン化合物として組成物全体を100質量%として、5質量%以下が好ましく、これを超えると、使用後の感触が重くなったり、ぬるつきを生じたりと、使用感が悪くなる。 In still another embodiment, the cosmetic of the present invention contains an organic acid salt and/or an inorganic acid salt of an amidoamine compound obtained by completely or partially neutralizing the amidoamine compound with a neutralizing agent such as an organic acid and/or an inorganic acid. Furthermore, the conditioning effect can be improved by adding a higher fatty acid and/or a higher alcohol. The amount of the compound is preferably 5% by mass or less based on 100% by mass of the entire composition as an amidoamine compound, and if it exceeds this amount, the feeling after use becomes heavy or the product feels slimy and the usability deteriorates.
本発明の化粧料に配合されるその他の成分としては、カチオン界面活性剤(アルキルトリメチルアンモニウム塩、ジアルキルジメチルアンモニウム塩、アルキルピリジニウム塩、アルキルジメチルベンジルアンモニウム塩、塩化ベンゼトニウム、塩化ベンザルコニウム、塩化ステアリルトリメチルアンモニウム等)、可溶化剤(エタノール、エチレングリコール、プロピレングリコール等)、ワックス類(ミツロウ、カルナバロウ、キャンデリラロウ等)、炭化水素油(流動パラフィン、スクワラン、オリーブ油、ホホバ油、アボガド油、ツバキ油、馬油等)、保湿剤(グリセリン、トレハロース、ソルビトール、マルチトール、ジプロピレングリコール、1,3−ブチレングリコール、アテロコラーゲン、ヒアルロン酸ナトリウム、加水分解ヒアルロン酸、アセチル化ヒアルロン酸、ヒアルロン酸ジメチルシラノール、セラミド、フィトグリコーゲン、加水分解卵殻膜、等)、エステル類(ラウリン酸ヘキシル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、ミリスチン酸ミリスチル、ミリスチン酸−2−ヘキシルデシル、トリミリスチン酸グリセリン、パルミチン酸イソプロピル、パルミチン酸−2−ヘプチルウンデシル、パルミチン酸−2−ヘキシルデシル、ステアリン酸ブチル、ステアリン酸イソセチル、12−ヒドロキシステアリン酸コレステリル、セトステアリルアルコール、オクタン酸セチル、ジメチルオクタン酸ヘキシルデシル、イソステアリン酸イソセチル、トリイソステアリン酸トリメチロールプロパン、オレイン酸デシル、オレイン酸オイル、乳酸セチル、乳酸ミリスチル、酢酸エチル、酢酸ブチル酢酸アミル、酢酸ラノリン、2−エチルヘキサン酸セチル、2−エチルヘキシルパルミテート、ジ−2−エチルヘキシル酸エチレングリコール、トリ−2−エチルヘキシル酸トリメチロールプロパン、トリ−2−エチルヘキシル酸グリセリン、テトラ−2−エチルヘキシル酸ペンタエリスリトール、セチル−2−エチルヘキサノエート、アジピン酸ジイソブチル、アジピン酸−2−ヘプチルウンデシル、アジピン酸−2−ヘキシルデシル、ジペンタエリスリトール脂肪酸エステル、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、アセトグリセライド、N−ラウロイル−L−グルタミン酸−2−オクチルドデシルエステル、セバシン酸ジ−2−エチルヘキシル、セバシン酸ジイソプロピル、コハク酸−2−エチルヘキシル、クエン酸トリエチル、エチルラウレート、ミンク油脂肪酸エチル等)、酸化防止剤(トコフェロール、BHT等)、シリコーン(メチルポリシロキサン、メチルフェニルポリシロキサン、高重合度メチルポリシロキサン、環状ポリシロキサン等)およびシリコーン誘導体(ポリエーテル変性シリコーン、アミノ変性シリコーン等)、高級アルコール(セチルアルコール、ステアリルアルコール、ベヘニルアルコール、イソステアリルアルコール、バチルアルコール等)、多価アルコール(グリセリン、ジグリセリン、プロピレングリコール、ポリエチレングリコール、ペンチレングリコール等)、高級脂肪酸(ラウ
リン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、イソステアリン酸、オレイン酸、ウンデシレン酸、トール油脂肪酸、ヤシ油脂肪酸、パーム脂肪酸、パーム核脂肪酸、リノール酸、リノレイン酸、エイコサペンタエン酸、ドコサヘキサエン酸等)、アミノ酸類(アルギニン、グルタミン酸、グリシン、アラニン、ヒドロキシプロリン、システイン、セリン、L−テアニン等)、紫外線吸収剤(ベンゾフェノン誘導体、パラアミノ安息香酸誘導体、メトキシ桂皮酸誘導体等)、紫外線反射剤(酸化チタン、酸化亜鉛等)、パール化剤(脂肪酸エチレングリコール等)、懸濁剤(ポリスチレン乳化物等)、増粘剤(セルロースエーテル、カルボキシビニルポリマー、キサンタンガム、パルミチン酸デキストリン等)、金属封鎖剤(エデト酸塩、エチドロン酸塩等)、pH調整剤、殺菌剤、防腐剤(メチルパラベン、エチルパラベン、ブチルパラベン、プロピルパラベン、フェノキシエタノール等)、育毛剤、起泡増進剤、タンパク質加水分解物(例えば、ケラチンペプチド、コラーゲンペプチド、大豆ペプチド、コムギペプチド、ミルクペプチド、シルクペプチド、卵白ペプチド等)、天然物エキス(クジンエキス、カジルエキス、テンチカエキス、海草エキス、ユーカリエキス、ローヤルゼリーエキス、ローズマリーエキス、ブナの木エキス等)、その他の機能性成分(コエンザイムQ10、アルブチン、ポリクオタニウム―51、エラスチン、白金ナノコロイド、パルミチン酸レチノール、パンテノール、アラントイン、ジラウロイルグルタミン酸リシンナトリウム等)、リン脂質ポリマー、ビタミン類、抗炎症剤、色素、香料等が挙げられる。
Other components to be added to the cosmetic of the present invention include cationic surfactants (alkyl trimethyl ammonium salt, dialkyl dimethyl ammonium salt, alkyl pyridinium salt, alkyl dimethyl benzyl ammonium salt, benzethonium chloride, benzalkonium chloride, stearyl chloride). Trimethylammonium, etc.), solubilizers (ethanol, ethylene glycol, propylene glycol, etc.), waxes (beeswax, carnauba wax, candelilla wax, etc.), hydrocarbon oils (liquid paraffin, squalane, olive oil, jojoba oil, avocado oil, camellia) Oil, horse oil, etc., moisturizer (glycerin, trehalose, sorbitol, maltitol, dipropylene glycol, 1,3-butylene glycol, atelocollagen, sodium hyaluronate, hydrolyzed hyaluronic acid, acetylated hyaluronic acid, dimethylsilanol hyaluronate , Ceramide, phytoglycogen, hydrolyzed egg shell membrane, etc.), esters (hexyl laurate, isopropyl myristate, octyldodecyl myristate, myristyl myristate, 2-hexyldecyl myristate, glyceryl trimyristate, isopropyl palmitate) , 2-heptylundecyl palmitate, 2-hexyldecyl palmitate, butyl stearate, isocetyl stearate, cholesteryl 12-hydroxystearate, cetostearyl alcohol, cetyl octanoate, hexyldecyl dimethyloctanoate, isocetyl isostearate. , Trimethylolpropane triisostearate, decyl oleate, oil oleate, cetyl lactate, myristyl lactate, ethyl acetate, butyl acetate amyl acetate, lanolin acetate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, di-2- Ethylene glycol ethylhexylate, trimethylolpropane tri-2-ethylhexylate, glycerin tri-2-ethylhexylate, pentaerythritol tetra-2-ethylhexylate, cetyl-2-ethylhexanoate, diisobutyl adipate, adipic acid-2- Heptylundecyl, 2-hexyldecyl adipate, dipentaerythritol fatty acid ester, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, glyceride tri-2-heptylundecanoate, castor oil Fatty acid methyl ester, acetog Lyceride, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-ethylhexyl sebacate, diisopropyl sebacate, 2-ethylhexyl succinate, triethyl citrate, ethyl laurate, mink oil fatty acid ethyl etc.), Antioxidants (tocopherol, BHT, etc.), silicones (methyl polysiloxane, methylphenyl polysiloxane, high degree of polymerization methyl polysiloxane, cyclic polysiloxane, etc.) and silicone derivatives (polyether-modified silicone, amino-modified silicone, etc.), higher alcohols (Cetyl alcohol, stearyl alcohol, behenyl alcohol, isostearyl alcohol, batyl alcohol, etc.), polyhydric alcohol (glycerin, diglycerin, propylene glycol, polyethylene glycol, pentylene glycol, etc.), higher fatty acid (lauric acid, myristic acid, palmitic acid) , Stearic acid, behenic acid, isostearic acid, oleic acid, undecylenic acid, tall oil fatty acid, coconut oil fatty acid, palm fatty acid, palm kernel fatty acid, linoleic acid, linoleic acid, eicosapentaenoic acid, docosahexaenoic acid, etc., amino acids (arginine) , Glutamic acid, glycine, alanine, hydroxyproline, cysteine, serine, L-theanine, etc.), UV absorbers (benzophenone derivatives, paraaminobenzoic acid derivatives, methoxycinnamic acid derivatives, etc.), UV reflectors (titanium oxide, zinc oxide, etc.) , Pearlizing agent (fatty acid ethylene glycol etc.), suspension agent (polystyrene emulsion etc.), thickener (cellulose ether, carboxyvinyl polymer, xanthan gum, dextrin palmitate etc.), sequestering agent (edetate salt, etidronic acid) Salts, etc.), pH adjusters, bactericides, preservatives (methylparaben, ethylparaben, butylparaben, propylparaben, phenoxyethanol, etc.), hair restorers, foam boosters, protein hydrolysates (eg, keratin peptides, collagen peptides, Soybean peptide, wheat peptide, milk peptide, silk peptide, egg white peptide, etc.), natural product extracts (kujin extract, kasil extract, tenchika extract, seaweed extract, eucalyptus extract, royal jelly extract, rosemary extract, beech tree extract, etc.), and other functions Sex ingredients (Coenzyme Q10, arbutin, polyquaternium-51, elastin, platinum nanocolloid, retinol palmitate, panthenol, Allantoin, sodium lysine dilauroylglutamate, etc.), phospholipid polymers, vitamins, anti-inflammatory agents, pigments, fragrances and the like.
以下実施例により本発明を説明する。ただし本発明は、これらの実施例および比較例によって何ら制限されるものではない。 The present invention will be described below with reference to examples. However, the present invention is not limited to these Examples and Comparative Examples.
[合成例1:カチオン化ヒアルロン酸の調製(1)]
48質量%の水酸化ナトリウム水溶液29.3gを60容量%のイソプロパノール水溶液733mLに添加した後、ここに低分子量ヒアルロン酸(分子量5000Da)100gを徐々に添加し分散させ、分散液を得た。
次に、上記分散液に、80質量%グリシジルトリメチルアンモニウムクロリド(以下GTAとも記す)水溶液66.8gを加え、加温し、50℃で3時間反応させた。反応終了後、35%塩酸36.7gを加え、反応系を中和した。室温で1時間混合後、メタノール5000mLに反応液を注ぎ、反応生成物を沈殿させ、濾別した。得られた沈殿物をメタノール水溶液にて洗浄した後、反応生成物を減圧下で乾燥した。このようにして得られたカチオン化ヒアルロン酸(試料番号1)のカチオン化度は0.70であり、GPCによる分子量測定の結果は6600(数平均分子量)であった。結果を表1に示す。
[合成例2〜5:カチオン化ヒアルロン酸の調製(2)]
上記合成例1と同様の手順にて、ただし添加するGTAの量を変更することにより、或いは分子量の異なるヒアルロン酸を原料として用いることにより、カチオン化度および分子量の異なるカチオン化ヒアルロン酸(試料番号2〜試料番号5)を調製した。
[Synthesis Example 1: Preparation of cationized hyaluronic acid (1)]
After adding 29.3 g of 48 mass% sodium hydroxide aqueous solution to 733 mL of 60 vol% isopropanol aqueous solution, 100 g of low molecular weight hyaluronic acid (molecular weight 5000 Da) was gradually added and dispersed therein to obtain a dispersion liquid.
Next, 66.8 g of an 80% by mass glycidyltrimethylammonium chloride (hereinafter also referred to as GTA) aqueous solution was added to the above dispersion liquid, heated, and reacted at 50° C. for 3 hours. After the reaction was completed, 36.7 g of 35% hydrochloric acid was added to neutralize the reaction system. After mixing at room temperature for 1 hour, the reaction solution was poured into 5000 mL of methanol to precipitate a reaction product, which was separated by filtration. The obtained precipitate was washed with a methanol aqueous solution, and then the reaction product was dried under reduced pressure. The cationized hyaluronic acid (Sample No. 1) thus obtained had a cationization degree of 0.70 and a molecular weight measured by GPC of 6600 (number average molecular weight). The results are shown in Table 1.
[Synthesis Examples 2 to 5: Preparation of Cationized Hyaluronic Acid (2)]
By the same procedure as in Synthesis Example 1 above, but by changing the amount of GTA to be added or using hyaluronic acid having a different molecular weight as a raw material, a cationized hyaluronic acid having a different cationization degree and a different molecular weight (Sample No. 2 to sample number 5) were prepared.
以下に調製したカチオン化ヒアルロン酸の一覧を示す。
なお、本実施例において、カチオン化ヒアルロン酸のGPCによる分子量(数平均分子量)の測定条件は以下の通りである。
・使用機器:LC−10ADvp[(株)島津製作所製]
・使用カラム:Shodex(登録商標) OHpak SB−802.5 HQ + OHpak SB−803 HQ[昭和電工(株)製]
・溶離液:0.1M硝酸ナトリウム
・流速:1mL/分
・オーブン温度:40℃
・測定時間:60分
・検量線
東ソー(株)製
TSKゲル標準ポリエチレンオキシド SE−8 分子量:101000
SE−2 27700
ジーエルサイエンス(株)製
ポリエチレングリコール 2070−9 分子量: 8650
2070−8 6450
2070−7 4250
2070−6 1470
In this example, the conditions for measuring the molecular weight (number average molecular weight) of cationized hyaluronic acid by GPC are as follows.
-Device used: LC-10ADvp [Shimadzu Corporation]
-Use column: Shodex (registered trademark) OHpak SB-802.5 HQ + OHpak SB-803 HQ [manufactured by Showa Denko KK]
・Eluent: 0.1 M sodium nitrate ・Flow rate: 1 mL/min ・Oven temperature: 40°C
-Measurement time: 60 minutes-Calibration curve Tosoh Corporation TSK gel standard polyethylene oxide SE-8 Molecular weight: 101000
SE-2 27700
GL Science Co., Ltd. polyethylene glycol 2070-9 molecular weight: 8650
2070-8 6450
2070-7 4250
2070-6 1470
〔実施例1:カチオン化ヒアルロン酸の吸着性評価〕
[試験手順]
種々のカチオン化度および分子量を有するカチオン化ヒアルロン酸に関して、毛髪への吸着性、皮膚真皮線維芽細胞への吸着性、皮膚表皮角化細胞への吸着性、および3次元培養皮膚への吸着性について、以下の手順に従いそれぞれ評価した。
なお上記種々の評価に用いたヒアルロン酸等を以下(a)〜(i)に示す。また(b)〜(f)、(h)及び(i)のヒアルロン酸類(以降、カチオン化の有無に関係なく実施例に供したヒアルロン酸を総称してヒアルロン酸類と称する)は精製水の添加により1質量%水溶液として実際の試験に供した。また(g)は精製水の添加により10質量%水溶液としたものを実際の試験に供した。
(a)精製水
(b)高分子量ヒアルロン酸ナトリウム[市販品、ヒアルロン酸分子量:1.37〜1.53×106Da、1質量%水溶液にて試験を実施]
(c)低分子量ヒアルロン酸[市販品、ヒアルロン酸分子量:1万以下、1質量%水溶液にて試験を実施]
(d)低分子量ヒアルロン酸ナトリウム[市販品、ヒアルロン酸分子量:7000、1質
量%水溶液にて試験を実施]
(e)高分子量カチオン化ヒアルロン酸[市販品、ヒアルロン酸分子量:50万〜80万、1質量%水溶液にて試験を実施]
(f)低分子量カチオン化ヒアルロン酸[上記試料番号1の低分子量カチオン化ヒアルロン酸、1質量%水溶液にて試験を実施]
(g)低分子量カチオン化ヒアルロン酸[上記試料番号1の低分子量カチオン化ヒアルロン酸、10質量%水溶液にて試験を実施]
(h)低分子量カチオン化ヒアルロン酸[上記試料番号4の低分子量カチオン化ヒアルロン酸、1質量%水溶液にて試験を実施]
(i)低分子量カチオン化ヒアルロン酸[上記試料番号5の低分子量カチオン化ヒアルロン酸、1質量%水溶液にて試験を実施]
[Example 1: Evaluation of adsorption of cationized hyaluronic acid]
[Procedure of test]
Regarding cationized hyaluronic acid with various degrees of cationization and molecular weight, it is adsorbable to hair, dermal fibroblasts, skin epidermal keratinocytes, and three-dimensional cultured skin. Was evaluated according to the following procedures.
The hyaluronic acid and the like used in the above various evaluations are shown in (a) to (i) below. Further, (b) to (f), (h) and (i) of hyaluronic acid (hereinafter, hyaluronic acid used in the examples regardless of the presence or absence of cationization is generically referred to as hyaluronic acid) is added to purified water. Was subjected to an actual test as a 1% by mass aqueous solution. Further, (g) was made into a 10 mass% aqueous solution by adding purified water and subjected to an actual test.
(A) Purified water (b) High molecular weight sodium hyaluronate [commercial product, hyaluronic acid molecular weight: 1.37 to 1.53×10 6 Da, tested with 1 mass% aqueous solution]
(C) Low molecular weight hyaluronic acid [commercial product, hyaluronic acid molecular weight: 10,000 or less, test with 1% by mass aqueous solution]
(D) Low molecular weight sodium hyaluronate [commercial product, hyaluronic acid molecular weight: 7,000, tested with 1% by mass aqueous solution]
(E) High-molecular-weight cationized hyaluronic acid [commercial product, hyaluronic acid molecular weight: 500,000 to 800,000, tested with 1% by mass aqueous solution]
(F) Low molecular weight cationized hyaluronic acid [Tested with 1% by weight aqueous solution of low molecular weight cationized hyaluronic acid of Sample No. 1 above]
(G) Low molecular weight cationized hyaluronic acid [Tested with low molecular weight cationized hyaluronic acid of Sample No. 1 above, 10% by mass aqueous solution]
(H) Low-molecular-weight cationized hyaluronic acid [Tested with low-molecular-weight cationized hyaluronic acid of Sample No. 4 above, 1% by mass aqueous solution]
(I) Low-molecular-weight cationized hyaluronic acid [Tested with low-molecular-weight cationized hyaluronic acid of Sample No. 5 above, 1% by mass aqueous solution]
[1]毛髪への吸着性試験
2%過酸化水素を含有する2%アンモニア水溶液に人毛黒髪((株)ビューラックスより入手)を30分浸漬した後、水洗し、ダメージ毛を調製した。
上記試料(a)〜(g)に、調製したダメージ毛を10分間浸漬した。10分後、毛髪を流水で洗浄し、キムタオル(登録商標)に毛髪を挟みこんで余分な水分を除去した。スライドガラスにセロハンテープで毛髪を固定した後、3質量%ウシ血清アルブミン(BSA)含有リン酸緩衝液(以下3%BSA含有PBSとも称する)によりブロッキングを行った。ブロッキング後、ビオチン標識ヒアルロン酸結合蛋白(HABP)およびストレプトアビジン標識TRITC(テトラメチルローダミンイソチオシアネート)により、毛髪に吸着しているヒアルロン酸類を蛍光標識した。標識後、蛍光退色防止剤を滴下してカバーガラスをかけて封入した後、蛍光観察を行った。
[1] Adhesion test on hair Human black hair (obtained from Vyrax Co., Ltd.) was dipped in a 2% aqueous ammonia solution containing 2% hydrogen peroxide for 30 minutes and washed with water to prepare damaged hair.
The prepared damaged hair was dipped in the samples (a) to (g) for 10 minutes. After 10 minutes, the hair was washed with running water, and the hair was pinched in Kim Towel (registered trademark) to remove excess water. After fixing the hair to the slide glass with cellophane tape, blocking was performed with a phosphate buffer containing 3 mass% bovine serum albumin (BSA) (hereinafter also referred to as PBS containing 3% BSA). After blocking, hyaluronic acid adsorbed on hair was fluorescently labeled with biotin-labeled hyaluronan-binding protein (HABP) and streptavidin-labeled TRITC (tetramethylrhodamine isothiocyanate). After the labeling, a fluorescent discoloration preventing agent was dropped and a cover glass was put on and sealed, and then fluorescence observation was performed.
[2]皮膚真皮線維芽細胞への吸着性試験
96ウェルプレートに皮膚真皮線維芽細胞を5×104細胞/cm2の密度で播種し、3日間培養した。3日後、精製水でリンスし、上記試料(a)〜(i)を10分間作用させた。10分後、精製水で3回リンスを行い、4質量%パラホルムアルデヒド/リン酸緩衝液(以下4%PFA/PBSとも称する)を作用させヒアルロン酸類を固定した。その後、3%BSA含有PBSによりブロッキングを行った。ブロッキング後、Hoechst(ヘキスト)33342により線維芽細胞の核を蛍光標識し、またビオチン標識HABPおよびストレプトアビジン標識TRITCにより線維芽細胞に吸着しているヒアルロン酸類を蛍光標識した。標識後、蛍光退色防止剤を滴下し、蛍光観察を行った。
[2] Adhesion test to skin dermal fibroblasts Skin dermal fibroblasts were seeded in a 96-well plate at a density of 5×10 4 cells/cm 2 and cultured for 3 days. After 3 days, the sample was rinsed with purified water and the samples (a) to (i) were allowed to act for 10 minutes. After 10 minutes, the product was rinsed three times with purified water, and a 4 mass% paraformaldehyde/phosphate buffer solution (hereinafter also referred to as 4% PFA/PBS) was allowed to act thereon to fix hyaluronic acid. After that, blocking was performed with PBS containing 3% BSA. After blocking, the nuclei of fibroblasts were fluorescently labeled with Hoechst 33342, and hyaluronic acid adsorbed to the fibroblasts was fluorescently labeled with biotin-labeled HABP and streptavidin-labeled TRITC. After the labeling, a fluorescent discoloration preventing agent was dropped, and fluorescence was observed.
[3]皮膚表皮角化細胞への吸着性試験
96ウェルプレートに皮膚表皮角化細胞を5×104細胞/cm2の密度で播種し、3日間培養した。3日後、精製水でリンスし、上記試料(a)〜(i)を10分間作用させた。10分後、精製水で3回リンスを行い、4%PFA/PBSを作用させヒアルロン酸類を固定した。その後、3%BSA含有PBSによりブロッキングを行った。ブロッキング後、Hoechst(ヘキスト)33342により角化細胞の核を蛍光標識し、またビオチン標識HABPおよびストレプトアビジン標識TRITCにより角化細胞に吸着しているヒアルロン酸類を蛍光標識した。標識後、蛍光退色防止剤を滴下し、蛍光観察を行った。
[3] Adhesion test to skin epidermal keratinocytes Skin epidermal keratinocytes were seeded in a 96-well plate at a density of 5×10 4 cells/cm 2 and cultured for 3 days. After 3 days, the sample was rinsed with purified water and the samples (a) to (i) were allowed to act for 10 minutes. After 10 minutes, rinsing with purified water was performed three times, and 4% PFA/PBS was allowed to act thereon to fix hyaluronic acids. After that, blocking was performed with PBS containing 3% BSA. After blocking, the nucleus of keratinocytes was fluorescently labeled with Hoechst 33342, and hyaluronic acid adsorbed to the keratinocytes was fluorescently labeled with biotin-labeled HABP and streptavidin-labeled TRITC. After the labeling, a fluorescent discoloration preventing agent was dropped, and fluorescence was observed.
[4]3次元培養皮膚への吸着性試験
I型コラーゲンと線維芽細胞からなる真皮と、角化細胞からなる表皮とを有する3次元培養皮膚を作製し、培養皮膚表面を精製水でリンスした。リンス後、上記試料(a)〜(g)を10分間作用させた。10分後、精製水で3回リンスを行い、4%PFS/PBSを作用させ、4℃にて1日間、3次元培養皮膚にヒアルロン酸類を固定した。固定後、4%PFS/PBSを30%スクロースに置換して4℃にて1日静置した後、再度30%ス
クロースに置換して4℃にて1日静置した(計2回スクロース置換を実施)。置換後、クリオスタット(サーモフィッシャーサイエンティフィック(株)、CryoStar NX70)を用いて三次元培養皮膚の凍結切片を作製した。その後、3%BSA含有PBSによりブロッキングを行った。ブロッキング後、Hoechst(ヘキスト)33342により線維芽細胞および角化細胞の核を蛍光標識し、またビオチン標識HABPおよびストレプトアビジン標識TRITCにより皮膚表面上に吸着しているヒアルロン酸類を蛍光標識した。標識後、蛍光退色防止剤を滴下してカバーガラスをかけて封入した後、蛍光観察を行った。
[4] Adsorption test to three-dimensional cultured skin Three-dimensional cultured skin having dermis composed of type I collagen and fibroblasts and epidermis composed of keratinocytes was prepared, and the surface of the cultured skin was rinsed with purified water. .. After rinsing, the samples (a) to (g) were allowed to act for 10 minutes. After 10 minutes, rinsing with purified water was performed 3 times, 4% PFS/PBS was allowed to act, and hyaluronic acid was immobilized on the three-dimensional cultured skin for 1 day at 4°C. After fixation, 4% PFS/PBS was replaced with 30% sucrose and allowed to stand at 4°C for 1 day, then replaced with 30% sucrose again and allowed to stand at 4°C for 1 day (total 2 times sucrose replacement). Carried out). After the replacement, a cryosection of the three-dimensional cultured skin was prepared using Cryostat (CryoStar NX70, Thermo Fisher Scientific Co., Ltd.). After that, blocking was performed with PBS containing 3% BSA. After blocking, the fibroblast and keratinocyte nuclei were fluorescently labeled with Hoechst 33342, and hyaluronic acid adsorbed on the skin surface was fluorescently labeled with biotin-labeled HABP and streptavidin-labeled TRITC. After the labeling, a fluorescent discoloration preventing agent was dropped and a cover glass was put on and sealed, and then fluorescence observation was performed.
[蛍光観察の画像解析]
上記[1]〜[4]で得られた蛍光観察画像(蛍光顕微鏡写真)を用い、毛髪および細胞へのヒアルロン酸類の吸着量を画像解析によって評価した。
画像解析には、画像解析ソフト「NIS−Elements B.R.3.1」((株)ニコン製)を用い、輝度の閾値[スレショルド]を統一して解析することにより、吸着量(率)として数値化した。
<毛髪の評価>
取得画像より毛髪1本を切り出し、毛髪自体の輝度の閾値、並びにヒアルロン酸類が吸着した部分の輝度の閾値を設定し、これらの強度の比較より、その毛髪に対する吸着(残留)ヒアルロン酸類の量の割合を解析した。
毛髪への吸着量(%)=吸着ヒアルロン酸類の輝度(閾値:900〜4078)/毛髪全体の輝度(閾値:350〜4078)
<細胞の評価>
細胞は画像全体に分布していることを考慮し、取得画像全体が細胞全体を表すと捉えて評価を行った。すなわち画像全体に関してヒアルロン酸類が吸着した部分の輝度の閾値を設定し、画像全体に対するヒアルロン酸類の吸着部分の強度を、細胞に対する吸着(残留)ヒアルロン酸類の量の割合として解析した。
細胞への吸着量(%)=吸着ヒアルロン酸量(閾値:1200〜4078)
[Image analysis of fluorescence observation]
Using the fluorescence observation images (fluorescence micrographs) obtained in [1] to [4] above, the amount of hyaluronic acid adsorbed on hair and cells was evaluated by image analysis.
Image analysis software "NIS-Elements BR 3.1" (manufactured by Nikon Corporation) was used for image analysis, and the adsorption amount (rate) was determined by unifying and analyzing the brightness threshold value [threshold]. Was quantified as
<Evaluation of hair>
One hair is cut out from the acquired image, the threshold of the brightness of the hair itself and the threshold of the brightness of the part where the hyaluronic acid is adsorbed are set, and the comparison of these intensities shows that the amount of adsorbed (residual) hyaluronic acid on the hair is determined. The percentage was analyzed.
Adsorption amount on hair (%)=luminance of adsorbed hyaluronic acid (threshold value: 900 to 4078)/luminance of entire hair (threshold value: 350 to 4078)
<Evaluation of cells>
Considering that the cells were distributed in the entire image, it was evaluated that the entire acquired image represents the entire cell. That is, the threshold value of the brightness of the portion where the hyaluronic acid was adsorbed in the entire image was set, and the intensity of the portion where the hyaluronic acid was adsorbed to the entire image was analyzed as the ratio of the amount of adsorbed (residual) hyaluronic acid to the cells.
Adsorption amount to cell (%) = Adsorption amount of hyaluronic acid (threshold value: 1200-4078)
[評価結果]
[1]毛髪への吸着性試験結果
蛍光顕微鏡による観察結果(写真)を図1に、画像解析による毛髪への吸着率の算出結果を以下の表2に示す。
図1より確認できるように、試料(f)および(g)の輝度は他の試料(a)〜(e)と比べても高く、また表2に示す通り、本発明の低分子量カチオン化ヒアルロン酸の水溶液である試料(f)および(g)は、毛髪への吸着性が最も高いことが確認された。
[1] Results of Adhesion Test on Hair The results of observation (photograph) by a fluorescence microscope are shown in FIG. 1, and the results of calculation of the adsorption rate on hair by image analysis are shown in Table 2 below.
As can be seen from FIG. 1, the brightness of the samples (f) and (g) is higher than that of the other samples (a) to (e), and as shown in Table 2, the low molecular weight cationized hyalurone of the present invention is used. It was confirmed that Samples (f) and (g), which are aqueous solutions of acids, had the highest adsorptivity to hair.
[2]皮膚真皮線維芽細胞への吸着性試験結果
試料(a)〜(g)に関する蛍光顕微鏡による観察結果(写真)を図2に、試料(a)、(f)、(h)及び(i)に関する蛍光顕微鏡による観察結果(写真)を図3に、試料(a)〜(i)に関する画像解析による皮膚真皮線維芽細胞への吸着率の算出結果を以下の表3に示す。図2及び図3において、(1)は蛍光標識した細胞核の画像を表し、(2)は蛍光標識したヒアルロン酸類の画像を表す。なお図2及び図3並びに表3(表3−1及び表3−2)における相違は、画像解析における輝度の閾値を変更したことによるものである。
図2に示すように、試料(a)〜(e)において(1)画像は細胞核が明確に確認できるが、(2)画像においてヒアルロン酸類を示す蛍光は輝度が低く不鮮明であり、これら試料では皮膚真皮線維芽細胞に殆ど吸着していないことが確認された。
一方、試料(f)および(g)では、(1)画像に示す細胞核を目安として確認できるように、(2)画像においてカチオン化ヒアルロン酸の皮膚真皮線維芽細胞への吸着を示す蛍光が鮮明に確認された。
また、図3に示すように、試料(f)、(h)及び(i)のいずれにおいても、これらカチオン化ヒアルロン酸の皮膚真皮線維芽細胞への吸着性が確認された。
さらに表3に示すように、本発明の低分子量カチオン化ヒアルロン酸の水溶液である試料(f)、(g)、(h)、(i)が、皮膚真皮線維芽細胞への吸着性が高く、特に試料(f)、(g)および(i)が高いことが確認された。
As shown in FIG. 2, in the samples (a) to (e), the cell nuclei can be clearly confirmed in the image (1), but in the image (2), the fluorescence indicating hyaluronan has low brightness and is unclear. It was confirmed that it was scarcely adsorbed to the skin dermal fibroblasts.
On the other hand, in the samples (f) and (g), the fluorescence showing the adsorption of the cationized hyaluronic acid to the skin dermal fibroblasts is clear in the image (2) so that the cell nucleus shown in the image (1) can be confirmed as a guide. Was confirmed.
Further, as shown in FIG. 3, in any of Samples (f), (h) and (i), the adsorbability of these cationized hyaluronic acid to the skin dermal fibroblasts was confirmed.
Further, as shown in Table 3, the samples (f), (g), (h), and (i), which are the aqueous solution of the low molecular weight cationized hyaluronic acid of the present invention, have high adsorptivity to skin dermal fibroblasts. It was confirmed that the samples (f), (g) and (i) were particularly high.
[3]皮膚表皮角化細胞への吸着性試験結果
試料(a)〜(g)に関する蛍光顕微鏡による観察結果(写真)を図4に、試料(a)、(f)、(h)及び(i)に関する蛍光顕微鏡による観察結果(写真)を図5に、試料(a)〜(i)に関する画像解析による皮膚表皮角化細胞への吸着率の算出結果を以下の表4に示す。図4及び図5において、(1)は蛍光標識した細胞核の画像を表し、(2)は蛍光標識したヒアルロン酸の画像を表す。なお図4及び図5並びに表4(表4−1及び表4−2)における相違は、画像解析における輝度の閾値を変更したことによるものである。
先の皮膚真皮線維芽細胞と同様に、図4において試料(a)〜(e)は(1)画像では細胞核が明確に確認できるが、(2)画像においてヒアルロン酸類を示す蛍光は輝度が低く不鮮明であり、これら試料では皮膚表皮角化細胞に殆ど吸着していないことが確認された。
一方、試料(f)および(g)では、(1)画像に示す細胞核を目安として確認できるように、(2)画像においてカチオン化ヒアルロン酸の皮膚表皮角化細胞への吸着を示す蛍光が鮮明に確認された。
また、図5に示すように、試料(f)、(h)及び(i)のいずれにおいても、これらカチオン化ヒアルロン酸の皮膚表皮角化細胞への吸着性が確認された。
さらに表4に示すように、本発明の低分子量カチオン化ヒアルロン酸の水溶液である試料(f)、(g)、(h)および(i)が、皮膚表皮角化細胞への吸着性が最も高いことが確認された。
Similar to the skin dermal fibroblasts described above, in the samples (a) to (e) in FIG. 4, the cell nuclei can be clearly confirmed in the image (1), but the fluorescence showing hyaluronic acid is low in the image (2). It was unclear and it was confirmed that these samples hardly adsorbed on the skin epidermal keratinocytes.
On the other hand, in the samples (f) and (g), the fluorescence indicating the adsorption of the cationized hyaluronic acid to the skin epidermal keratinocytes is clear in the image (2) so that the cell nucleus shown in the image (1) can be confirmed as a guide. Was confirmed.
Further, as shown in FIG. 5, in any of Samples (f), (h), and (i), the adsorbability of these cationized hyaluronic acid to skin epidermal keratinocytes was confirmed.
Further, as shown in Table 4, the samples (f), (g), (h) and (i), which are the aqueous solution of the low molecular weight cationized hyaluronic acid of the present invention, have the highest adsorptivity to skin epidermal keratinocytes. It was confirmed to be high.
[4]三次元培養皮膚への吸着性試験結果
蛍光顕微鏡による観察結果(写真)を図6に示す。なお図6において、各図の矢印が培養皮膚の上面を指し、これより上部の蛍光は試料のヒアルロン酸類の吸着部分を示し、これより下部の蛍光は皮膚内部(産生)のヒアルロン酸を示す。
図6に示すように、試料(a)〜(e)は培養皮膚上面へのヒアルロン酸類の吸着による蛍光は殆どみられず、一方試料(f)および(g)では明確にカチオン化ヒアルロン酸の吸着による蛍光が確認できた。
[4] Adsorption test result to three-dimensional cultured skin The observation result (photograph) with a fluorescence microscope is shown in FIG. In FIG. 6, the arrow in each figure indicates the upper surface of the cultured skin, the fluorescence above this indicates the adsorbed portion of the hyaluronic acid of the sample, and the fluorescence below this indicates hyaluronic acid inside the skin (produced).
As shown in FIG. 6, in samples (a) to (e), fluorescence due to adsorption of hyaluronic acid on the upper surface of the cultured skin was hardly observed, while in samples (f) and (g), cationized hyaluronic acid was clearly detected. Fluorescence due to adsorption was confirmed.
〔実施例2:カチオン化ヒアルロン酸の相溶性評価〕
上記試料(e)高分子量カチオン化ヒアルロン酸(1質量%水溶液)および試料(f)低分子量カチオン化ヒアルロン酸(1質量%水溶液)を用い、各種化粧品原料との相溶性を評価した。
下記表5に示す化粧品原料の水溶液を同表に記載の終濃度の2倍の濃度で準備し、これと、上記試料(e)または(f)の溶液とを質量比で1:1にて撹拌混合して静置し、混合液外観を目視にて確認し、以下の判定基準により評価した。得られた結果を表5に示す(表中、%は質量%を示す)。
なお表5に示す濃度は化粧品原料の終濃度を示し、例えば混合時に化粧品原料の水溶液の濃度:1質量%、ヒアルロン酸類の溶液の濃度1質量%とすると、終濃度はいずれも0.5質量%となる(本実施例においてヒアルロン酸類の終濃度は全て0.5質量%である)。
また配合時のpHは、化粧品原料の水溶液及びヒアルロン酸類の溶液の各々のpHをクエン酸及び水酸化ナトリウム水溶液にて調整したものである。
<判定基準>
○ :透明
× :霞〜半透明状
××:不溶物析出
[Example 2: Compatibility evaluation of cationized hyaluronic acid]
Using the sample (e) high molecular weight cationized hyaluronic acid (1% by mass aqueous solution) and the sample (f) low molecular weight cationized hyaluronic acid (1% by mass aqueous solution), compatibility with various cosmetic raw materials was evaluated.
An aqueous solution of cosmetic raw material shown in Table 5 below was prepared at a concentration twice the final concentration shown in the same table, and this and the solution of the sample (e) or (f) were mixed at a mass ratio of 1:1. The mixture was stirred, mixed and allowed to stand still, the appearance of the mixed solution was visually confirmed, and evaluated according to the following criteria. The obtained results are shown in Table 5 (in the table,% indicates mass %).
The concentrations shown in Table 5 indicate the final concentration of the cosmetic raw material. For example, when the concentration of the aqueous solution of the cosmetic raw material during mixing is 1% by mass and the concentration of the solution of hyaluronic acid is 1% by mass, the final concentration is 0.5% by mass. % (In this example, the final concentration of hyaluronic acid is 0.5% by mass).
The pH at the time of compounding is the pH of each of the aqueous cosmetic raw material solution and the hyaluronic acid solution adjusted with citric acid and an aqueous sodium hydroxide solution.
<Judgment criteria>
○: transparent ×: haze to semitransparent × ×: insoluble matter precipitation
また、精製水、そして化粧品原料としてラウリル硫酸ナトリウム(終濃度:0.5質量%、10質量%)、グリセリン(同:5質量%、20質量%)、ソルビトール(同:5質量%、20質量%)、ブチレングリコール(同:5質量%、20質量%)および加水分解ダイズタンパク(同:5質量%)を使用した場合の上記ヒアルロン酸類との混合液外観について、静置後写真を図7に示す(図中、%は質量%を示す)。図7中、それぞれの写真は、各写真上部に示す化粧品原料(濃度は終濃度)と、左から(1)精製水との1:1混合液、(2)試料(e)との1:1混合液、(3)試料(f)との1:1混合液(いずれも配合時pH:5−6)を示したものである。
さらに、カチオン化セルロース(終濃度:0.5質量%)、ポリクオタニウム−7(同:0.5質量%)、エタノール(同:20質量%)を使用した場合の上記ヒアルロン酸類との混合液外観について、静置後写真を図8に示す(図中、%は質量%を示す)。図8中
、それぞれの写真は、各写真上部に示す化粧品原料(濃度は終濃度)と、左から(4)精製水との1:1混合液、(5)試料(f)低分子量カチオン化ヒアルロン酸(1質量%水溶液)との1:1混合液、(6)試料(e)高分子量カチオン化ヒアルロン酸(1質量%水溶液)との1:1混合液(いずれも配合時pH:5−6)を示したものである。
Also, purified water, and sodium lauryl sulfate (final concentration: 0.5% by mass, 10% by mass), glycerin (the same: 5% by mass, 20% by mass), sorbitol (the same: 5% by mass, 20% by mass) as a raw material for cosmetics. %), butylene glycol (the same: 5% by mass, 20% by mass) and the hydrolyzed soybean protein (the same: 5% by mass), the appearance of the mixed solution with the above hyaluronic acid is shown in FIG. (In the figure,% indicates mass %). In FIG. 7, each photograph is a 1:1 mixture of the cosmetic raw material (concentration is the final concentration) shown in the upper part of the photograph and (1) purified water from the left, and (2) sample (e) 1: 1 mixture, (3) 1:1 mixture with the sample (f) (all pH at the time of compounding: 5-6).
Furthermore, the appearance of a mixed liquid with the above hyaluronic acid when cationized cellulose (final concentration: 0.5% by mass), polyquaternium-7 (same: 0.5% by mass), and ethanol (same: 20% by mass) are used. 8 shows a photograph after standing (in the figure,% indicates mass %). In Fig. 8, each photograph is a 1:1 mixture of cosmetic raw materials (concentration is final concentration) shown in the upper part of each photograph and (4) purified water from the left, (5) sample (f) low molecular weight cationization 1:1 mixture with hyaluronic acid (1% by weight aqueous solution), (6) sample (e) 1:1 mixture with high molecular weight cationized hyaluronic acid (1% by weight aqueous solution) -6) is shown.
表5に示すように、本発明が対象とする試料(f)低分子量カチオン化ヒアルロン酸は、種々の化粧品原料に対して幅広いpH値で相溶性を有する結果となった(図7及び図8参照)。一方、試料(e)高分子カチオン化ヒアルロン酸は、カチオン性水溶性ポリマーにおいて半透明状なり、相溶性に欠け、またエタノールではpHや濃度によって不溶物が析出し、相溶性に大きく劣るとする結果が得られた(特に図8参照)。 As shown in Table 5, the sample (f) low molecular weight cationized hyaluronic acid targeted by the present invention resulted in compatibility with various cosmetic raw materials in a wide pH range (FIGS. 7 and 8). reference). On the other hand, it is assumed that the sample (e) high molecular cationized hyaluronic acid becomes semi-transparent in the cationic water-soluble polymer and lacks compatibility, and in ethanol, insoluble matter precipitates depending on pH and concentration, resulting in large incompatibility. Results were obtained (see especially FIG. 8).
〔実施例3:カチオン化ヒアルロン酸の毛髪内浸透性評価〕
試料(c)低分子量ヒアルロン酸(1質量%水溶液)、試料(e)高分子量カチオン化ヒアルロン酸(1質量%水溶液)および試料(f)低分子量カチオン化ヒアルロン酸(1質量%水溶液)200mLに、上記実施例1[1]毛髪への吸着性試験にて調製したダメージ毛(長さ10cm)を40℃、60分間浸漬した。その後、毛髪を取り出し湿度50%、温度25℃の恒温恒湿内で12時間乾燥した。得られた毛髪を切断し、断面をToF−SIMSにより分析し、定性スペクトルにより検出されたヒアルロン酸類のm/z値を特定し、該m/z値にてマッピングすることにより、毛髪内部へのヒアルロン酸類の浸透性を評価した。
[Example 3: Evaluation of permeability of cationized hyaluronic acid into hair]
Sample (c) low molecular weight hyaluronic acid (1% by weight aqueous solution), sample (e) high molecular weight cationized hyaluronic acid (1% by weight aqueous solution) and sample (f) low molecular weight cationized hyaluronic acid (1% by weight aqueous solution) to 200 mL The damaged hair (length 10 cm) prepared in the above Example 1 [1] Hair adsorption test was immersed at 40° C. for 60 minutes. Then, the hair was taken out and dried for 12 hours in a thermo-hygrostat at a humidity of 50% and a temperature of 25°C. The obtained hair is cut, the cross section is analyzed by ToF-SIMS, the m/z value of hyaluronic acid detected by the qualitative spectrum is specified, and the m/z value is mapped to the inside of the hair. The permeability of hyaluronic acids was evaluated.
定性スペクトル分析より、試料(c)低分子量ヒアルロン酸はm/z=126,128において、試料(e)高分子量カチオン化ヒアルロン酸はm/z=274において、そして試料(f)低分子量カチオン化ヒアルロン酸はm/z=134において、それぞれ特徴的なピークが観測された。 From qualitative spectrum analysis, sample (c) low molecular weight hyaluronic acid at m/z=126,128, sample (e) high molecular weight cationized hyaluronic acid at m/z=274, and sample (f) low molecular weight cationized Characteristic peaks of hyaluronic acid were observed at m/z=134.
各試料のヒアルロン酸類由来の特徴的なm/z値における毛髪断面のマッピング結果を図9(2)に示す。図9(2)中、輝度の高い部分がヒアルロン酸類の分布を反映しており、図9(1)には毛髪断面の分析エリア(枠で囲まれた部分)を表示した。
図9に示すように、本発明が対象とする試料(f)低分子量カチオン化ヒアルロン酸は、毛髪断面内部まで分布(浸透)していることが確認され、一方、試料(e)高分子量カチオン化ヒアルロン酸は毛髪表面(毛髪外周)の分布にとどまることが確認できた。なお、(c)低分子量ヒアルロン酸は画像全面で検出されているように見えるが、バックグラウンドの影響が強いための結果と言え、毛髪断面の分析エリア近辺で強度の強弱は確認されず、毛髪表面への吸着および毛髪内部への浸透には至らなかったとみられる結果となった。
FIG. 9(2) shows the mapping result of the hair cross section at the characteristic m/z value derived from hyaluronic acid of each sample. In FIG. 9(2), the high-brightness portion reflects the distribution of hyaluronic acids, and FIG. 9(1) shows the analysis area (the portion surrounded by a frame) of the hair cross section.
As shown in FIG. 9, it was confirmed that the sample (f) low molecular weight cationized hyaluronic acid targeted by the present invention was distributed (penetrated) to the inside of the hair cross section, while sample (e) high molecular weight cation It was confirmed that the modified hyaluronic acid remained in the distribution on the hair surface (outer periphery of the hair). It should be noted that (c) low molecular weight hyaluronic acid seems to be detected on the entire surface of the image, but it can be said that the result is due to the strong influence of the background. The results seem to have not reached the surface adsorption and the permeation into the hair.
〔実施例4:カチオン化ヒアルロン酸配合化粧料の官能評価〕
下記組成を有する美容液に対して、試料(g)低分子量カチオン化ヒアルロン酸(10質量%水溶液)を0.1質量%配合し(低分子量カチオン化ヒアルロン酸の最終濃度:0.01%)、未配合の美容液との官能評価に供した。
Sample (g) 0.1% by mass of low molecular weight cationized hyaluronic acid (10% by mass aqueous solution) was added to a beauty essence having the following composition (final concentration of low molecular weight cationized hyaluronic acid: 0.01%). , Was subjected to a sensory evaluation with an unblended beauty essence.
20〜70代女性の被験者:333人に対して、上記試料(g)配合の美容液と未配合の美容液をそれぞれ左右の手の甲に別々に同量塗布し、なじませた。
その後、試料(g)未配合の美容液を塗布した手の甲の感触(A)と、試料(g)配合の美容液を塗布した手の甲の感触(B)について、感触の変化を比較した。
感触(B)が感触(A)よりも保湿効果や整肌効果の点で優れていると評価した被験者は327人(98%)となり、これら感触に変化がないと評価した被験者は6人(2%)となった。
Female subjects in their 20's to 70's: The same amount of the sample (g)-containing cosmetic liquid and the unmixed cosmetic liquid were separately applied to the 333 persons on the backs of the left and right hands and made to spread.
Then, the change in the feel was compared between the feel (A) of the back of the hand coated with the sample (g) unmixed beauty essence and the feel of the back of the hand coated with the sample (g) blended beauty essence.
327 (98%) of the subjects evaluated that the feel (B) was superior to the feel (A) in terms of moisturizing effect and skin conditioning effect, and 6 subjects evaluated that these feelings did not change ( 2%).
以下に上記試料番号1〜4を用いた種々の化粧料の処方例を実施例5乃至実施例19として示す。なおここに記載した試料番号の低分子量カチオン化ヒアルロン酸のみならず、上記表1に示す他の試料番号の低分子量カチオン化ヒアルロン酸を用いた場合であっても、同様に保湿性等に優れる各種化粧料が得られた。 Hereinafter, prescription examples of various cosmetics using the above sample numbers 1 to 4 are shown as Examples 5 to 19. Not only the low molecular weight cationized hyaluronic acid of the sample number described here, but also the low molecular weight cationized hyaluronic acid of the other sample numbers shown in the above Table 1 are similarly excellent in the moisturizing property. Various cosmetics were obtained.
[実施例5:化粧水]
常法に基づき、表7の成分を配合し、化粧水を製造した。
下記配合の化粧水は、使用後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 7 were blended to produce a lotion.
The lotion of the following formulation was extremely excellent in the moist feeling (moisture retention) of the skin after use.
[実施例6:ボディケアローション]
常法に基づき、表8の成分を配合し、ボディケアローションを製造した。
下記配合のボディケアローションは、使用後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 8 were blended to produce a body care lotion.
The body care lotion having the following composition was extremely excellent in the moist feeling (moisturizing property) of the skin after use.
[実施例7:美容液]
常法に基づき、表9の成分を配合し、美容液を製造した。
下記配合の美容液は、使用後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 9 were blended to produce a beauty essence.
The beauty essence of the following formulation was extremely excellent in the moist feeling (moisturizing property) of the skin after use.
[実施例8:ボディソープ(ボディシャンプー)(1)]
常法に基づき、表10の成分を配合し、ボディソープを製造した。
下記配合のボディーソープは、洗浄後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 10 were blended to produce a body soap.
The body soap having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the skin after washing.
[実施例9:ボディソープ(ボディシャンプー)(2)]
常法に基づき、表11の成分を配合し、ボディソープを製造した。
下記配合のボディーソープは、洗浄後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 11 were blended to produce a body soap.
The body soap having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the skin after washing.
[実施例10:洗顔料(1)]
常法に基づき、表12の成分を配合し、洗顔料を製造した。
下記配合の洗顔料は、洗浄後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 12 were blended to produce a face wash.
The facial cleansers of the following formulations were extremely excellent in moisturizing feeling (moisturizing property) after washing.
[実施例11:洗顔料(2)]
常法に基づき、表13の成分を配合し、洗顔料を製造した。
下記配合の洗顔料は、洗浄後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 13 were blended to produce a face wash.
The facial cleansers of the following formulations were extremely excellent in moisturizing feeling (moisturizing property) after washing.
[実施例12:アフターシェーブローション]
常法に基づき、表14の成分を配合し、アフターシェーブローションを製造した。
下記配合のアフターシェーブローションは、使用後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 14 were blended to produce an aftershave lotion.
The after shave lotion having the following composition was extremely excellent in the moist feeling (moisture retention) of the skin after use.
[実施例13:入浴剤]
常法に基づき、表15の成分を配合し、入浴剤を製造した。
下記配合の入浴剤は、入浴後の肌のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 15 were blended to produce a bath salt.
The bath agents having the following formulations were extremely excellent in the moist feeling (moisturizing property) of the skin after bathing.
[実施例14:シャンプー(1)]
常法に基づき、表16の成分を配合し、シャンプーを製造した。
下記配合のシャンプーは、洗髪後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 16 were blended to produce a shampoo.
The shampoo having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of hair after washing.
[実施例15:シャンプー(2)]
常法に基づき、表17の成分を配合し、シャンプーを製造した。
下記配合のシャンプーは、洗髪後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 17 were blended to produce a shampoo.
The shampoo having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of hair after washing.
[実施例16:リンス(1)]
常法に基づき、表18の成分を配合し、リンスを製造した。
下記配合のリンスは、適用・洗浄後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 18 were blended to produce a rinse.
The rinse having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the hair after application and washing.
[実施例17:リンス(2)]
常法に基づき、表19の成分を配合し、リンスを製造した。
下記配合のリンスは、適用・洗浄後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients in Table 19 were blended to produce a rinse.
The rinse having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the hair after application and washing.
[実施例18:ヘアジェル]
常法に基づき、表20の成分を配合し、ヘアジェルを製造した。
下記配合のヘアジェルは、適用後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the ingredients shown in Table 20 were blended to produce a hair gel.
The hair gel having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the applied hair.
[実施例19:ヘアワックス]
常法に基づき、表21の成分を配合し、ヘアワックスを製造した。
下記配合のヘアワックスは、適用後の毛髪のしっとり感(保湿性)に極めて優れているものであった。
Based on a conventional method, the components shown in Table 21 were blended to produce a hair wax.
The hair wax having the following composition was extremely excellent in moisturizing feeling (moisturizing property) of the applied hair.
Claims (4)
前記低分子量カチオン化ヒアルロン酸および/またはその塩は、下記式で表されるカチオン化度が0.60乃至0.70である、化粧料。
The low molecular weight cationized hyaluronic acid and/or its salt has a cationization degree represented by the following formula of 0.60 to 0.70.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014248447 | 2014-12-08 | ||
JP2014248447 | 2014-12-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016108344A JP2016108344A (en) | 2016-06-20 |
JP6715592B2 true JP6715592B2 (en) | 2020-07-01 |
Family
ID=56121784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015239629A Active JP6715592B2 (en) | 2014-12-08 | 2015-12-08 | Cosmetics containing low molecular weight cationized hyaluronic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6715592B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020011094A (en) * | 2018-04-20 | 2020-11-06 | Procter & Gamble | Spatial imaging of scalp care agents. |
JP2020002050A (en) * | 2018-06-27 | 2020-01-09 | 小林製薬株式会社 | Skin washing agent composition |
WO2021075413A1 (en) | 2019-10-15 | 2021-04-22 | 株式会社コーセー | External preparation for skin |
CN115884812A (en) * | 2020-09-17 | 2023-03-31 | 株式会社资生堂 | Cleaning composition |
CN113773412B (en) * | 2021-09-18 | 2022-08-16 | 中国科学院烟台海岸带研究所 | Process for the preparation of anionic polysaccharide derivatives |
CN114213556B (en) * | 2021-12-31 | 2022-11-15 | 南京乐韬生物科技有限公司 | Low-molecular-weight cationized hyaluronate and preparation method and application thereof |
CN114983855B (en) * | 2022-06-23 | 2023-07-11 | 北京化工大学 | Composite peptide with tyrosinase activity inhibition function, and preparation method and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62292710A (en) * | 1986-06-12 | 1987-12-19 | Lion Corp | Skin cosmetic |
JP2549119B2 (en) * | 1987-05-30 | 1996-10-30 | 三省製薬株式会社 | Topical |
WO2007099830A1 (en) * | 2006-02-24 | 2007-09-07 | Q.P. Corporation | Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition and food composition each using same |
CN101715457B (en) * | 2007-04-24 | 2013-01-02 | 丘比株式会社 | Cationized hyaluronic acid and/or salt thereof, method for producing the same, and hair modifying agent, cuticle repairing agent, skin modifying agent and cosmetic preparation each using the same |
JP2008285421A (en) * | 2007-05-15 | 2008-11-27 | Q P Corp | Hair modification penetrant and cosmetic for hair using the same |
JP5492400B2 (en) * | 2008-10-31 | 2014-05-14 | ホーユー株式会社 | Hair cosmetic composition |
TWI510501B (en) * | 2009-12-08 | 2015-12-01 | Kewpie Corp | Method for manufacturing purified hyaluronic acid group |
-
2015
- 2015-12-08 JP JP2015239629A patent/JP6715592B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016108344A (en) | 2016-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6715592B2 (en) | Cosmetics containing low molecular weight cationized hyaluronic acid | |
JP5241708B2 (en) | Cationized hyaluronic acid and / or salt thereof, method for producing the same, and hair modifying agent, cuticle restorative agent, skin modifying agent and cosmetics using the same | |
JP4975996B2 (en) | Cation-modified pectin and cosmetic composition containing the substance | |
JP6377020B2 (en) | Carboxymethyl group-containing modified hyaluronic acid and / or salt thereof, and cosmetics, food compositions and pharmaceutical compositions containing the same | |
JP4783064B2 (en) | Cation-modified agar and cosmetic composition containing the substance | |
JP4711069B2 (en) | Cation-modified alginic acid derivative and cosmetic composition containing the substance | |
JP4970762B2 (en) | Cation-modified psyllium seed gum and cosmetic composition containing the substance | |
JP2016532651A (en) | Dihydroxyalkyl-substituted polygalactomannan and process for producing the same | |
EP2537867A1 (en) | Modified hyaluronic acid and/or salt thereof, method for producing same and cosmetic comprising same | |
JP2007063446A (en) | Cation-modified xanthan gum and cosmetic composition comprising the same | |
JP2005330257A (en) | Cosmetic | |
JP2006241330A (en) | Cation modified purified tara gum and cosmetic composition containing the substance | |
JP2006241082A (en) | Cation-modified pure locust bean gum and cosmetic composition containing the substance | |
JP5064664B2 (en) | Cation-modified Karaya gum and cosmetic composition containing the substance | |
JP2007009092A (en) | Cationically modified gellan gum and cosmetic composition containing the same | |
JP2006152280A (en) | Cation-modified glucomannan polysaccharide and cosmetic composition containing the same | |
JP2008285421A (en) | Hair modification penetrant and cosmetic for hair using the same | |
CN110621295A (en) | Cosmetic composition | |
JP2006169410A (en) | Cationically modified purified guar gum and cosmetics composition containing the above material | |
TW201517912A (en) | Crosslinked product of carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof, and method for producing same | |
JP2016166133A (en) | Pack cosmetics | |
JP2015160818A (en) | hair cosmetic | |
JP6472038B2 (en) | Cosmetic oil and cosmetics containing the same | |
JP6207184B2 (en) | Cosmetics and external preparation for skin | |
WO2022044781A1 (en) | Gel composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181119 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190814 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190821 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191210 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200527 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200609 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6715592 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |